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Abstract 
Background: 
Acute Lymphoblastic Leukemia (ALL) is the most common cancer among Palestinian 
children. The high prevalence of malnutrition and low physical activity level in children 
with ALL are well-documented as the main treatment impacts. The present study aimed to 
assess the nutritional status and physical activity level of pediatric patients with ALL during 
treatment in Beit-Jala hospital and to compare them to healthy children.  
Methods: 
This cross-sectional descriptive study included 21 patients aged 2–12 years, who were 
diagnosed with acute lymphoblastic leukemia (ALL) during their treatments. Children in 
the cases group were matched to those in the control group in a ratio of 1:2 based on age 
and gender. Weight-for-age, weight-for- height, body mass index-for-age were taken and 
compared to the growth charts recommended by the world health organization. Mid-upper 
arm circumference, triceps skinfold thickness, arm muscle area and serum albumin level 
were determined. Physical activity was assessed using a validated questionnaire and 
compared to WHO recommendation. Dietary habits were assessed using a validated 
questionnaire and compared with the recommendations of the American Academy of 
Pediatrics.  
Findings: 
A total of 63 children participated in this study, of which 21 were children with acute 
lymphoblastic leukemia (ALL), and 42 were healthy children. With respect to the children 
with ALL and healthy children 38% of them were males and 62% were females. Their 
average age was 7.2 years. As for the place of residence, 43% of the children with acute 
lymphoblastic leukemia (ALL) were from Hebron Governorate, 24% were from Gaza strip, 
and 19% were from Bethlehem Governorate. However, the majority of healthy children 
were from Bethlehem governorate (93%). 
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The prevalence of malnutrition in children with ALL based on anthropometric variables 
were generally higher than controls, although the differences were statistically significant 
(P-value≤ 0.05). The results found that there were a statistically significant differences in 
the weight-for-age categories (p-value= 0.001) , weight-for-height categories (p-value = 
0.045), Arm Muscle Area categories (p-value = 0.011) , and physical activity level (p-value 
= 0.000) between children with ALL and healthy children. In addition, no significant 
differences were noted on BMI-for-age z-scores between children with ALL and healthy 
children (p-value = 0.124). 
The prevalence of malnutrition in children with ALL was high. So, based on BMI-for-age 
categories, 24% of the children with ALL were classified as obese, 14% of children with 
ALL were suffering severe thinness, and 10% of children with ALL were suffering thinness. 
Most notably, 62% of the children with ALL were classified with wasted muscles based on 
Arm Muscle Area. On the other hand, 76% of the children with ALL did not reach the 
recommended level of physical activity according to world health organization 
recommendation. 
Higher percentage of children with ALL did not reach the recommended level of food intake 
according to world health organization recommendation compared to controls, although the 
differences were statistically significant (P ≤ 0.05). The results found that there are 
statistically significant differences in the intake of fruits (p-value = 0.009), milk &dairy 
products (p-value= 0.028) and vegetables (p-value=0.047) (servings per day) between 
children with Acute Lymphoblastic Leukemia (ALL) and healthy children. 
Conclusions:  
Based on findings of this study, the prevalence of malnutrition in children with acute 
lymphoblastic leukemia was higher than healthy children. So, the disease &treatment given 
to children with ALL has an important effect on their growth rate, nutritional status, and 
physical activity. So, the importance of written policies about nutritional assessment, & 
intervention was indicated. In addition, the awareness of proper nutrition for ALL children 
is important to improve care and to decrease the prevalence of malnutrition. 
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  لأطفال اللوكيمياالنشاط البدني   ومستوىالحالة  التغذوية 
 اعداد: رولا بشارة البندك
  اشراف : د. أميرة عمرو
  باللغة العربية الملخص
 الخلفية: 
. ويعاني الأطفال المصابين في فلسطينال الأمراض السرطانية شيوعا بين الأطف أنواع إن سرطان الدم الليمفاوي هو أكثر
بسرطان الدم الليمفاوي من  ارتفاع معدل انتشار سوء التغذية وانخفاض معدل النشاط البدني. بالإضافة إلى ذلك ، فان سوء 
لأطفال المصابين بسرطان الدم الليمفاوي. هذه التغذية وانخفاض النشاط البدني هما العاملان الرئيسيين اللذان يؤثران على ا
الدراسة تهدف إلى تقييم الحالة التغذوية ومستوي النشاط البدني للأطفال المصابين بسرطان الدم الليمفاوي خلال فترة علاجهم 
 .السليمينفي مستشفى بيت جالا ومقارنتها بالأطفال 
 المنهجية :
عمارهم بين ،  تتراوح أخلال فترة علاجهمطفلا مصابا بسرطان الدم الليمفاوي  12دراسة وصفية مقطعية، تم تطبيقها على 
  تم قياس الوزن بالنسبةوعلى أساس العمر والجنس.  2:1بنسبه  السليمينمن الأطفال  مجموعة ب تهمسنة.  وتم مقارن 21-2
منظمة الصحة  احنيات النمو التي أوصت بهللعمر ، الوزن بالنسبة للطول ، مؤشر كتلة الجسم بالنسبة للعمر ومقارنتها مع من
العالمية. وكما تم قياس محيط منتصف أعلى الذراع وسمك العضلات الثلاثية بالإضافة إلى مساحة سطح عضلة الذراع 
مستوى مصل الزلال في الدم .وتم تقييم النشاط البدني باستخدام الاستبيان ومقارنته بتوصيات منظمه الصحة وقيس أيضا 
ة. بالإضافة إلى ذلك تم تقييم العادات الغذائية باستخدام الاستبيان ومقارنته مع توصيات الأكاديمية الأمريكية لطب العالمي
 الأطفال.
 :النتائج
. وتتكون  سليماطفلا  24طفل مصاب بسرطان الدم الليمفاوي و  12طفلا، منهم  36شارك في هذه الدراسة ما مجموعه 
 سنة. أما بالنسبة لمكان الإقامة ،فان  2.7% من الأطفال إناث، بمتوسط عمري 26%من الأطفال ذكور و  83العينة من 
% كانوا 91% كانوا من قطاع غزة، و 42م من محافظة الخليل ، و % من الأطفال المصابين بسرطان الدم الليمفاوي ه34
 .39 %كانوا  من محافظة بيت لحم بنسبة  السليمينمن محافظة بيت لحم ، لكن معظم الأطفال 
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وكانت نسبة انتشار سوء التغذية لدى أطفال اللوكيميا عند استخدام متغيرات النمو  بشكل عام أعلى لدى المرضي بالمقارنة 
، تبين من خلال النتائج ان هناك  50.0 ≤ eulav-p، مع إن الاختلافات تكون ذات دلاله إحصائية عند  السليمينالأطفال مع 
للطول  بالنسبة ومستوى الوزن )، )100.0 =eulav-pاختلافات ذات دلالة إحصائية في تصنيفات الوزن بالنسبة للعمر عند 
 mrA) و فئات مستوى العضلات في الذراع  000.0= eulav-p( ني عند) ومستوى النشاط  البد540.0=eulav-pعند (
. بالإضافة السليمينال بين الأطفال المصابين بسرطان الدم الليمفاوي والأطف)110.0=eulav-p(  عند  aerA elcsuM
فال المصابين بسرطان لم يلاحظ  وجود اختلاف ذو دلالة إحصائية وفقا لمؤشر كتلة الجسم بالنسبة للعمر بين الأط ،إلى ذلك
  .)921.0=eulav-pعند ( السليمينالدم الليمفاوي والأطفال 
وتبين ذلك عند استخدام مؤشر كتلة  .اوي عاليةكانت نسبة انتشار سوء التغذية لدى الأطفال المصابين بسرطان الدم الليمف
% من 01ي يعانون من النحافة الشديدة ، و % من الأطفال المصابين بسرطان الدم الليمفاو41الجسم بالنسبة للعمر، فكان 
      elcsuM mrA متغير وعند استخدام  الأطفال المصابين بسرطان الدم الليمفاوي يعانون من النحافة. بالإضافة إلى ذلك،
% من 67ن أون من ضعف العضلات . وتبين أيضا % من الأطفال المصابين بسرطان الدم الليمفاوي يعان26تبين أن aerA
الأطفال المصابين بسرطان الدم الليمفاوي يمارسون النشاط البدني بنسبة اقل من المعدل الموصى به من قبل منظمة الصحة 
 العالمية.
ما توصي به  منظمة وتبين أيضا أن نسبة كبيرة من الأطفال المصابين بسرطان الدم الليمفاوي يأكلون الطعام بكميات أقل من 
 eulav-p(.  .علي الرغم من إن الاختلافات تكن ذات دلاله إحصائية عند         السليمينالصحة العالمية ، مقارنة بالأطفال 
 eulav-pالنتائج أن هناك اختلافات ذات دلالة إحصائية في تناول الحصة اليومية من الفواكه عند  وأظهرت )50.0 ≤
بين الأطفال المصابين  )740.0 = eulav-p( والخضراوات 820.0=eulav-p عند نتجات الألبانوالحليب وم،  900.0=
 .السليمينبسرطان الدم الليمفاوي والأطفال 
 :الاستنتاج
، كان انتشار سوء التغذية أعلى لدى الأطفال المصابين بسرطان الدم الليمفاوي مقارنة بالأطفال  نتائج الدراسةواستنادا إلى 
الحالة . فان المرض و العلاج المعطى للأطفال المصابين بسرطان الدم الليمفاوي له تأثير هام على معدل النمو، وينالسليم
، وكيفية التعامل بة تتكون من طرق التقييم التغذوي. فهناك ضرورة للعمل على وضع سياسات مكتوالتغذوية، والنشاط البدني
السمنة. بالإضافة إلى نشر الوعي حول الطرق المثلى للتغذية وذلك لرفع مستوى العناية بالمرضى  ومع حالات سوء التغذية 
 .والتقليل من نسبة انتشار سوء التغذية بين الأطفال المصابين بسرطان الدم الليمفاوي
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Chapter one: Background  
 
1.1 Introduction 
 
The purpose of this chapter is to describe the problem, justification and significance of the 
study &research question. Leukemia is the most common cancer that influences children, 
representing about 25% of malignant diseases diagnosed in children under 20 years old (Al-
Mulla et al., 2014; Owens et al.,2013; Zhang et al., 2014). It might be defined as a neoplastic 
disease that influences the blood-forming tissues of the bone marrow, lymph nodes, and 
spleen (Tomlinson & Kline, 2010). 
There are two wide classifications of leukemia which are acute and chronic. The most 
common types of leukemia are:  
1. Acute Lymphoblastic Leukemia (ALL), which represents 75–80% of childhood 
leukemia.   
2.  Acute Myeloid Leukemia (AML), also known as acute non lymphoblastic leukemia 
(ANLL), which represents  20–25% of childhood leukemia (Tomlinson & Kline, 2010). 
 
Acute Lymphoblastic Leukaemia (ALL) was the most common cancer among Palestinian 
children in the West Bank in 2015 (Palestinian MOH, 2016). Acute Lymphoblastic 
Leukemia (ALL) is the most common prevalent type of blood and bone marrow cancer that 
happens among pediatrics and adolescents. Children who have ALL ailment are at higher 
risk for a large number of health problems ,for example, type 2 diabetes, dyslipidemias, 
cardiovascular disease, hypertension, secondary cancer, depression, malnutrition and lower 
quality of life (Kanellopoulos, Hamre, Dahl, Fossa, & Ruud, 2013). 
 
  
2 
 
The survival rate of children with ALL has increased. Recently, advances in treatment and 
technology over the last 30 years with enhanced survival rates (in excess of 80%) in pediatric 
oncology (Oeffinger et al., 2006). Likewise, cancer patients are in danger of irregularity of 
appetite and gradually exercise less as the disease advances and typically get less than the 
recommended level of exercise (Danaher et al., 2006;Pate et al., 1995). 
This study aims to assess the nutritional status and physical activity level of pediatric patients 
with ALL during treatment in Beit-Jala hospital and compare them to healthy children. 
1.2 Problem Statement 
During practice at Huda Al -Masri pediatric cancer department at Beit-Jala Hospital, it was 
noted that a high percentage of patients are suffering from general muscle weakness, 
increased weight, and lack of regularity in meals. Also, it was noted that proper nutritional 
assessment of patients, family education programs and clear policies for nutrition and 
physical activity of children with acute lymphatic leukemia are lacking. In addition, 
department of nutrition in the Palestinian ministry of health is concerned only about 
improving food and dietary services in hospitals, where one nutritionist is assigned to each 
hospital for this task. No specialized clinical dietitians are assigned to follow up on pediatric 
oncology patients. Also, no attention is being given to physical activity level, where no 
guidelines or policies are available.  
1.3 Justification and Significance of the study 
Assessing the nutritional status and physical activity level of ALL patients will help 
determine the need for nutritional care and will help to specify the nutritional problems that 
need to be take care of. In addition, assessing the physical activity level will help suggest 
providing tools and facilities for patients to do exercise. 
The results of this study can be used to put new policies about dietary habits and physical 
activity for children with acute lymphoblastic leukemia. Also, results may highlight the 
importance of expanding the role of nutritionists who work in hospitals. Results can also be 
used to implement educational sessions for acute lymphoblastic leukemia patients and their 
parents about dietary habits, problems that affect nutritional status and physical activity 
during hospitalization and their follow up on home visits and after discharge. 
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1.4 Aim of the study 
The main aim of the study is to assess the nutritional status and physical activity level of 
pediatric patients with ALL during treatment in Beit-Jala hospital and to compare them to 
healthy children. 
1.5 Objectives of the study 
The objectives of this study are: 
1. To assess the socio-demographic factors that may affect nutritional status and physical 
activity among children with ALL during treatment in Beit-Jala hospital. 
2. To determine the prevalence of malnutrition among children with ALL during treatment 
in Beit-Jala hospital. 
3. To evaluate the level of physical activity done by children with ALL during treatment 
in Beit-Jala hospital compared to healthy children. 
1.6 Research Questions: 
This investigation attempts to answer the following principle questions: 
Study Question Number 1: Is there a difference between healthy children and ALL patients 
in the nutritional status, dietary habits and physical activity? 
Study Question Number 2: What are the factors that may affect the nutritional status and 
physical activity during treatment of children with ALL? 
Study Question Number 3: Are there any differences between healthy children and children 
with ALL in growth? 
 
1.7 Research hypothesis 
1. There are no statistically significant differences at α= 0.05 between children with 
Acute lymphoblastic leukemia (ALL) and healthy children in their z-score of weight-
for-age. 
2. There are no statistically significant differences at α= 0.05 between children with 
Acute lymphoblastic leukemia (ALL) and healthy children in their z-score of Body 
Mass Index-for-age. 
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3. There is no statistically significant association between children with Acute 
lymphoblastic leukemia (ALL) and healthy children in their AMA (Arm Muscle 
Area). 
4. There are no statistically significant differences at α= 0.05 between children with 
Acute lymphoblastic leukemia (ALL) and healthy children in their z-score weight-
for-height. 
5. There are no statistically significant differences at α= 0.05 between children with 
Acute lymphoblastic leukemia (ALL) and healthy children in their physical activity 
level. 
6. There are no statistically significant differences at α= 0.05 between children with 
Acute lymphoblastic leukemia (ALL) and healthy children in their fruits servings for 
child per day according to age.  
7. There are no statistically significant differences at α= 0.05 between children with 
Acute Lymphoblastic Leukemia (ALL) and healthy children in their milk servings 
for child per day according to age. 
8. There are no statistically significant differences at α= 0.05 between children with 
Acute lymphoblastic leukemia (ALL) and healthy children in their vegetables 
servings for child per day according to age. 
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Chapter two: Literature review 
 
2.1 Introduction 
  Leukemia is the most common malignancy that influences children, representing for 
approximately one-third of cancer diagnoses in children in the United States (Tmilson & 
Kline, 2010). In addition, Acute Lymphoblastic Leukemia ( ALL) is the most common type 
of childhood cancer representing for approximately 25% of cancers diagnosed in children 
under 20 years old World Wide (Al-Mulla et al, 2014; Owens et al, 2013). It might be 
defined as a neoplastic disease that influences the blood-forming tissues of the bone marrow, 
lymph nodes, and spleen (Tmilson & Kline, 2010). Also, it is a clonal disease that outcome 
from genetic mutations and transformation of a single early progenitor myeloid or lymphoid 
cell during hematopoiesis. In leukemia, there is an overproduction of immature white blood 
cells that can’t work sufficiently. These immature white blood cells are commonly called 
“blasts, “for example, the myeloblasts, lymphoblasts, and monoblasts. In this way, the type 
of leukemia that results is dependent on the cell lineage that is influenced by the mutation 
(Tmilson & Kline, 2010). There are a lot of symptoms, but the most common symptoms of 
childhood ALL include lethargy, weakness, bone pain and loss of appetite (Salim et al., 
2014). 
2.2 The Classification of Childhood Leukemia  
 In children, the type and subtype of leukemia is determined by testing samples of blood and 
bone marrow which plays a major role in determining the treatment choices and predicts the 
prognosis of the disease(American Cancer Association, 2015). Leukemic cells regularly 
spread to other organs of the body such as the liver, spleen, lymph nodes, testes or central 
nervous system and if this happen, the treatment must be more intense in order to destroy 
the malignant cells (American Cancer Association, 2015). 
The most common types of leukemia are: 
1. Acute lymphoblastic leukemia (ALL), which represents 75–80% of childhood 
leukemia.  
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2. Acute myeloid leukemia (AML), also known as acute non-lymphoblastic leukemia 
(ANLL), which represents 20–25% of childhood leukemia.   
3. Chronic myeloid (or myelocytic) leukemia (CML), which represents fewer than 5% of 
childhood leukemia (Tmilson & Kline, 2010). 
2.3 Incidence of Acute Lymphoblastic Leukemia (ALL) 
ALL has been related to high morbidity and mortality rates among children worldwide and 
in Palestine. Global mortality rate is 11.9%, which is around 3-4 cases for each 100,000 of 
population under 15 years old (World Health organization, 2009). 
The highest incidence of ALL shows up in Europe and North America, with around 5 cases 
in 100,000 among 0–14-year-old children. The lowest incidence, about 0.9 in 100,000 
children has been observed in Kuwait and Mumbai. A recent study has demonstrated that 
the incidence of leukemia has expanded in Europe in the last decades with an average 0.6% 
yearly increase  (Kaatsch & Mergenthaler, 2008). In the Middle East, precursor B-cell ALL 
represent 84.2% and T-cell ALL represent 14.8% of Acute Lymphoblastic Leukemia. The 
peak age range at diagnosis is between 3-6 years in Middle East with gender proportion of 
male to female (1.4:1) (Al-Mulla et al., 2014).  
Leukemia in the Middle East was accounted for to be one of the ten most common 
malignancies and is the major type of pediatric cancer which represents for 39.4% of 
pediatric cancer diagnosis, it was found to happen in 36% of children diagnosed with 
pediatric cancer in the 0-10 year age group; 16 % in children in the 10-20 year age group 
and in 19% of subjects in the 20-30 year age group (Tadmouri et al., 2010).  
The number of reported pediatric ALL cases by hospitals in the West Bank in Palestine 
between 2009- 2015 was 119 cases. However, 68 cases were registered between the years 
of 2009-2015 in Huda Al-Masri pediatric cancer department at Beit-Jala Hospital. The 
number of reported ALL deaths in these hospitals in the West Bank from 2009-2015 was 9 
cases, with a mortality rate of 7.6 per 100 ALL cases (Palestinian MOH, 2016). 
 
 
 
  
7 
 
2.4 Etiology of ALL 
The malignant cells of Acute Lymphoblastic Leukemia (ALL) are lymphoid precursor cells 
(i.e., lymphoblasts) that are arrested in a starting stage of development. This arrest is brought 
about by an anomalous expression of genes, regularly because of chromosomal 
translocations. The lymphoblasts replace the normal marrow components, resulting in a 
marked decrease in the production of normal blood cells. Consequently, anemia, 
thrombocytopenia, and neutropenia occur to various degrees (M. Tan, Fong, Lo, & Young, 
2017). 
The components associated in the etiology of childhood cancers are still unclear. Different 
etiologies have been proposed and investigated, anyway few are well established. It would 
be misleading to entirely associate the reason of any childhood malignancy to genetic or 
environmental factors (Tmilson& Kline, 2010). The etiologic factors has not been 
completely established, however; it has been connected to a few strong risk factors ,for 
example, birth weight (Towers &Spector, 2007); the method of feeding (breastfeeding and 
artificial feeding) (Schraw et al., 2014); gender (Gholami et al., 2013); maternal diet 
(Petridou et al., 2005); being an identical twin (American Cancer Association, 2015); 
radiation exposure (Amitay & Keinan-Boker, 2015) and Trisomy 21 (Down's syndrome) 
(Inaba et al., 2013). 
2.5 The treatment of ALL 
There are three sorts of treatments offered to Children with acute lymphoblastic leukemia. 
These include chemotherapy, radiotherapy, and bone marrow transplantation. The multiple 
protocols of chemotherapy for ALL generally include the following phases: Induction, 
consolidation, Re-induction, CNS-directed therapy, Maintenance/continuing treatment. The 
main treatment for All are Chemotherapy and dexamethasone; these medications are given 
as intravenous, intramuscular, intra-thecal or as pills (Tmilson & Kline, 2010). The treatment 
is expected to  disrupting and devastating the growth and division of cancer cells. The 
treatment is systemic which makes damage to healthy cells in the skin, hair follicles, mucus 
membranes, reproductive system and the gastrointestinal tract resulting in hair loss 
(alopecia) which includes loss of body hair, eyebrows and eyelashes; malabsorption; 
mucositis and loss of  taste (Chan, 2007).  
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2.5.1 Induction phase 
In this phase children get a combination of drugs. The drugs used at first to induce a 
remission are vincristine, steroids (normally prednisone, and dexamethasone). What is more, 
a third medication L – asparaginase is typically given over a 4-week period. This three-
medicate induction usually produces remission in about 95% of children with standard risk 
classification. A fourth medication is an anthracycline over a 4–6-week time frame. 
Moreover, a fifth medication which is a daunorubicin, CNS prophylaxis/treatment is also 
begun during induction with Intra-Thecal chemotherapy (Methotroxate), because of the risk 
of Pneumocystis jiroveci pneumonia (PCP) in immune-compromised patients, 
sulfamethoxazole/trimethoprim is typically given as a prophylaxis(Tmilson& Kline, 2010). 
2.5.2 Consolidation phase 
This phase of treatment is given after induction, once there is evidence of normal 
hematopoietic function and remission is confirmed. The length of consolidation therapy 
ranges from around 4 to about two months. Consolidation therapy has concentrated 
treatment directed to the CNS (Tmilson & Kline, 2010).  
2.5.3 Re-induction (Re-intensification) 
This stage goes on for 2 months and aims at preventing the leukemia from returning 
(Children`s Oncology Group., 2015). It is basically a repetition of induction chemotherapy 
and it has been turned out to be an important component of ALL protocols. Common 
chemotherapeutic agents administered during re-intensification include vincristine, steroids, 
asparginase, and the addition of an anthracycline. Other common chemotherapeutic agents 
including cyclophosphamide, cytarabine, and methotrexate with mercaptopurine. 
Additionally this stage includes CNS-directed therapy (Tmilson & Kline, 2010). 
2.5.4 Maintenance/Continuing Treatment:  
The last period of treatment length between 2-3 years and is less aggressive than the past 
stages in that it mostly comprises of oral drugs given at home. Oral methotrexate 
administered once per week and oral 6-mercaptopurine administered once per day is the 
mainstay of most continuation regimens (Tmilson & Kline, 2010).Cancer treatment toxicity 
is a major limitation causing frequent dose limitations and interruptions in treatment plans 
(Chan, 2007). 
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2.6 Side effects of Leukemia treatment  
Treatment of leukemia influences the child psychologically, socially and also physically. 
And the treatment causes a lot of symptoms, however; the most well-known symptoms of 
childhood ALL include lethargy, fatigue, bone pain, pallor, fever and loss of appetite (Al-
Mulla et al., 2014; Salim et al., 2014). The treatment intends to disrupt and destroy the 
development and division of disease cells. The treatment is systemic which makes damage 
to healthy cells in the skin, hair follicles, mucus membranes, reproductive system and the 
gastrointestinal tract resulting in hair loss (alopecia) which incorporates loss of body hair, 
eyebrows and eyelashes, mal-absorption, mucositis and loss of taste (Chan, 2007). But, the 
most common symptoms caused by treatment of chemotherapy according to Children`s 
Oncology Group (2015) are: 
1. Fatigue, weight loss, easy bruising and bleeding. 
2. Infection, anemia (low red blood cells count). 
3. Nausea and vomiting, appetite changes, constipation, diarrhea. 
4. Mouth & tongue & throat problems such as sores and pain with swallowing. 
5. Nerve and muscle problems such as numbness, tingling, and pain. 
6. Skin and nail changes such as dry skin and color change. 
7. Urine and bladder changes and kidney problems. 
8. Mood changes, changes in libido and sexual function and fertility problems. 
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2.6.1 Weight changes 
Overweight, obesity and malnutrition are the main treatment impacts in children with ALL 
because glucocorticoid therapy used as a major part of the treatment protocol for ALL in 
children, has a symptom of causing unnecessary weight gain that can lead to obesity. This is 
common in children during and after treatment (Murphy et al, 2006; Withycombe et al., 
2015). 
Steroids are utilized to start negative anabolic impacts like an increased appetite causing an 
increased energy intake (Tan et al., 2013). According to Collins & others (2010) children on 
ALL medications on dexamethasone have a more prevalence of overweight/ obesity post 
induction remission(Collins et al., 2010). Other investigation has discovered a positive 
correlation between weights; BMI and skinfold measurement in children three years post 
ALL diagnosis (Lughetti et al., 2012). 
 Increased incidence of obesity has been noted in children who got treatment for acute 
lymphoblastic leukemia and brain tumor (Rogers et al., 2005). Co-factors that may increase 
the risk of overweight and obesity in childhood cancer survivors include: injury to the 
hypothalamic– pituitary axis, growth hormone insufficiency, excessive caloric intake 
associated with steroid treatment, and physical inactivity (Tomlinson & Kline, 2010).  
On the other hand, the study done in the Middle Eastern region by Al-Mulla et al (2014) 
found that 87.4 % of the subjects have a normal nutritional status dependent on the weight-
for-age of subjects at diagnosis and only 3.1% of subjects were observed to be obese. A 
retrospective study done by Withycombe et al (2015) demonstrated that the obesity is a 
medical issue that is common in children treated for ALL. In this study, obesity was present 
in 23% of childhood leukemia patients by the end of therapy while an additional 20% 
finished therapy as overweight. This implies that nearly half of ALL patients finished 
therapy with an unhealthy weight status, according to the study, leukemia patients suffer 
significantly from obesity (Withycombe et al., 2015). 
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2.6.2 Gastrointestinal complications of leukemia therapy 
Leukemia treatment, for example, chemotherapy cause gastrointestinal problems, these 
include diarrhea, constipation, and mucositis and diminished gastrointestinal motility. 
Diarrhea was found to impact a child`s dietary intake and absorption of nutrients which may 
lead to dehydration and electrolyte imbalances if untreated (Ladas et al .,2005). Obstruction 
has been frequently saw in children with cancer receiving vincristine containing regimens 
(Ladas et al, 2005). In addition, chemotherapy cause changes in taste perception like 
expanded sourness and bitterness or a metallic taste in children on treatment, this can 
contrarily affect the nutritional status and development of child; consequently the assessment 
of energy intake is important to do as a part of the nutritional assessment (Lades et al., 
2005).A significant number of children on cancer treatment create mucositis, pain and oral 
hemorrhage which diminish their oral intake and increment their risk for under-nutrition 
(Owens et al., 2013). In addition, the impacts of chemotherapy frequently include vomiting 
which damagingly effect on the gastrointestinal tract, making lesions and inflammation to 
the epithelial lining of the gut. This thus diminishes food intake and absorption. 
Chemotherapy causes nausea, diarrhea and taste changes prompting diminished food intake 
(Skolin et al., 2006). Chemotherapy in ALL patients has been reported to specifically affect 
the structure of the microbiota in the gut which directly influences nutrient availability and 
absorption and indirectly influences carbohydrate digestion and fermentation resulting in 
increased calorie absorption, obesity and insulin resistance (Rosen et al., 2013). 
2.6.3 Hyperglycemia 
One of the most important medications of leukemia treatment is Glucocorticoids however; 
they can increase blood glucose by blocking the impacts of insulin by expanding liver 
gluconeogenesis; L-asparaginase then again diminishes insulin levels (Dare et al., 2013). In 
addition, the chemotherapeutic agents have been found to alter the gut barrier which triggers 
the release of lipopolysaccharides delivered by the gram negative microbes in the digestive 
system, and this in turn causes metabolic endotoxemia that motivates insulin resistance 
(Rosen et al, 2013). 
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2.6.4 Physical activity changes 
Cancer patients slowly exercise less as the disease progresses and normally get less than the 
recommended level of activity (Danaher et al., 2006; Pate et al., 1995). Other pilot study 
done by Aznar & his colleagues (2006) aimed to measure physical activity (PA) levels in 
children with Acute Lymphoblastic Leukemia (ALL) and compare them to age-matched 
healthy children. The study found that a significantly lower level of complete week-by-week 
time and lower day-by-day times of activity were found in children being treated for ALL 
(Aznar et al., 2006). 
2.7 Nutrition care process for ALL Patients 
2.7.1 Nutrition screening & assessment of children with ALL 
Nutrition is an important variable when arranging the treatment of children with (ALL), 
because a good nutritional status helps children with ALL to adapt to the reactions of disease 
treatment by diminishing their risk of developing infections, which can negatively affect 
their quality of life and survival. Nutritional assessment is a combination of clinical 
assessment, dietary assessment, anthropometric assessment and biochemical assessment 
(Brown, 2011). According to Murphy & his colleagues (2015) over-nutrition and under-
nutrition are significant worries in the short- and long-term care of children with cancer. 
Children being treated for cancer have increased fat mass and diminished body cell 
mass(Murphy et al., 2015).   
2.7.1.1 Clinical/physical Assessment 
A clinical/physical assessment includes visual inspection of an individual by a trained 
registered dietitian or other qualified proficient to note features that might be related to 
malnutrition. For example: excessive or deficient muscle to fat ratio, paleness, bruises, and 
brittle hair. Physical attributes are nonspecific indicators, however they can support other 
findings related to nutritional status (Brown, 2011). 
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2.7.1.2 Dietary assessment: 
Many methods in practice are utilized for surveying diet history for clinical purposes, 24-
hour dietary reviews, 3 days food record and food records analyzed by computer programs 
are most common. Single, 24-hour reviews and food frequency questionnaires are most 
helpful for evaluating dietary intakes for groups, while multiple recalls and dietary histories 
are essential to use for assessments of individual diets and to estimate the macronutrient and 
micronutrient content of the child’s diet (Brown, 2011& Mosby et al,2009). 
2.7.1.2.1 24-Hour Dietary Recalls and Records 
The reason for its utilization is to evaluate an individual’s diet to estimate the individual's 
overall diet quality so that strengths and weaknesses can be recognized, or to assess intake 
of specific nutrients that might be associated with disease states  (Brown, 2011). 
2.7.1.2.2 Food Frequency Questionnaires 
Food frequency questionnaires are utilized to evaluate food and nutrient intake of groups of 
people. These instruments are viewed as semi-quantitative because they force people into 
describing food intake dependent on a set number of food decisions and portion sizes. 
Validated food frequencies are relatively inexpensive to administer and tabulate, and they 
provide good enough estimates of dietary intake to rank individuals by their food and 
nutrient intake levels (Brown, 2011) . They tend to under estimate food intake and provide 
data that are more likely to fail to recognize nutrient and health relationships than are 
quantitative assessment techniques like the dietary history (Brown, 2011). Malnutrition is 
related by regimens low in nutrients-dense vegetables and fruits, low fat diets, and diets high 
in saturated fats (Americans Dietry Guidlines, 2015). 
2.7.1.3 Anthropometric Assessment 
Individual measures of body size for examples (height, weight, percent body fat, head and 
waist circumferences, body mass index, and skin fold thicknesses, mid upper arm 
circumference) are helpful in the evaluation of nutritional status—whenever done 
effectively. Each measure requires utilization of standard methods and aligned via trained 
personnel (Brown, 2011). 
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2. 7.1.3.1 weight 
Is one of the primary markers in nutritional status and can be impacted by a patient`s body 
composition, fluid status, medication, organ enlargement or tumor mass. At the point when 
represented on a growth chart, the weight-for-age of a child is indicative of a child`s weight 
compared with other children of a similar age and gender. It is likewise valuable for tracking 
weight gain in infants and children, as well as, to clarify changes in weight-for-length or 
BMI-for-age. Weight-for-age can be utilized to classify a child as `underweight or 
overweight (World Health organization, 1997). A study done in the Middle Eastern area by 
Al-Mulla & others (2014) on 1150 ALL subjects found 87.4% of the subjects to have a 
normal nutritional status dependent on the weight for age of subjects at diagnosis and just 
3.1% of subjects were observed to be obese at diagnosis. Increased incidence of obesity has 
been noted in children who got treatment for acute lymphoblastic leukemia and brain tumors 
(Rogers et al., 2005).  
2.7.1.3.2 Height /Length 
Length is estimated for infants and toddlers who are two years of age or less, standing height 
or stature is estimated. Length is an indicator of a child`s linear growth relative to age and is 
utilized to characterize the shortness or tallness of a child. At the point when plotted on a 
growth chart, the length or height-for-age of a child demonstrates the child`s length/height 
in contrast with other children of a similar age and gender and reflects the long-term 
nutritional status; as length/height is influenced more gradually than weight when a child 
experiences under nutrition or over nutrition (Bunting et al., 2013). Under nutrition may 
cause poor linear growth or stunting which results in the child`s height being not as much as 
his/her hereditary potential and over nutrition may result in early maturation and accelerated 
linear growth, resulting in a child being tall for age. A gain in height/ stature is said to happen 
more gradually than a gain in weight and may in this manner require an extended time of 
nutritional rehabilitation to achieve (Bunting et al., 2013). 
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2.7.1.3.3 Body Mass index (BMI)  
Is a screening tool which is age and gender specific and is utilized to recognize children who 
are under or overweight (Bunting et al., 2013). Body mass index is predictive of body fat for 
children more than 2 years old, as BMI normative values are not available for children under 
2 years old (Brown, 2011). For children 2 years of age or older, a BMI in the 85thpercentile 
or greater but less than the 95th percentile indicates overweight, and a BMI in the 95th 
percentile or more indicates obesity (Brown, 2011). A weight-for-length or a BMI-for-age 
percentile less than the fifth percentile indicates underweight (Brown, 2011). In addition, if 
the height of child more than 2 years old is estimated standing, the 2-to-20-years growth 
chart is utilized to recognize the percentile. According to Bauer &others (2011), BMI is the 
least complex, most noninvasive and acceptable tool that is utilized to, in a roundabout way, 
measure body fatness which can be related to adiposity and wellbeing dangers in children in 
later life (Bauer et al.,2011). Some cross-sectional studies were compared between healthy 
and ALL children with age and sex-matched, found that on-treatment patients have 
significantly more obese than healthy patients (Murphy et al., 2006). 
Another study done by Touyz & colleagues (2016) found that there are significant and 
persistent increments in BMI z-score in children with ALL treated on a protocol that didn’t 
utilize cranial radiation or glucocorticoids during maintenance. Maximal increments in BMI 
were found to occur during the dexamethasone in induction and re-induction phase of ALL 
treatment (Touyz et al., 2016). 
2.7.1.3.4 Triceps skinfold thickness  
The triceps skinfold site is on the back part of the right arm, over the triceps muscle, halfway 
between the lateral projection of the acromion procedure of the scapula and the inferior 
margin of the olecranon procedure of the ulna (Lee & Nieman, 2016).The evaluation of 
skinfold thickness is an objective measure of adiposity, an estimation of a twofold layer of 
skin and fat tissue on the back of the upper arm (Brown, 2011). 
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2.7.1.3.5 Mid Upper Arm Circumference (MUAC) 
Mid-Upper Arm Circumference (MUAC) is the boundary of the upper arm, estimated at the 
mid-point between the tip of the shoulder and the tip of the elbow (Brown, 2011). MUAC is 
a better indicator for pediatric nutrition status. Among less than 5 years old children, mid 
upper arm circumference (MUAC) is the mainstay of identification of malnutrition in the 
community and increasingly utilized in health facilities. Estimating MUAC is less expensive 
and simpler than estimating weight and height and is less influenced by acute dehydration 
than weight based records (Mwangome , Fegan & Prentice , 1992). 
2.7.1.3.6 Arm Muscle Area (AMA) 
Arm muscle area (AMA) is utilized as an index of lean tissue or muscle in the body, it is 
determined by utilization mid upper-arm circumferences, thickness of the triceps skinfold, 
and is utilized as an index of fat stores, and arm muscle size is utilized to represent muscle 
protein reserves. As the measure of arm muscle changes because of growth, development, 
and nutritional status, the subsequent change in arm muscle area is more prominent than the 
change in mid-arm circumference. Consequently, changes in upper-arm musculature are not 
as effectively identified by estimation of mid-arm circumference as by estimation of AMA. 
Therefore, AMA is the preferred nutritional index. AMA is corresponded with creatinine 
excretion in children (Lee & Nieman, 2016). 
The standard equation for calculating arm muscle area (AMA) is: 
AMA= [𝑀𝐴𝐶 − (𝜋 × 𝑇𝑆𝐹)]2 ÷ 4π 
Where AMA is arm muscle area in mm²; MAC mid-arm circumference in mm; and TSF 
triceps skinfold thickness in mm. Utilization of this equation depends on the following 
assumptions: 
1.  In cross section, both the mid-arm and mid-arm muscle compartments are round. 
2. The triceps skinfold-thickness is double the normal thickness of the subcutaneous fat 
layer.  
3. Bone atrophies in proportion to muscle wasting in protein-energy malnutrition. 
4.  The cross-sectional area of bone and the sheath containing the nervous and vascular 
tissues of the upper arm are little and insignificant. Truly, however, a few of these 
elements are significant sources of error in evaluating AMA (Lee & Nieman, 2016). 
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This variable were interpreted in accordance with the Frisancho (1993) percentiles Charts 
(Frisancho, 1993). 
2.7.1.3.7 Growth charts 
Growth charts are tools consisting of a progression of percentiles and curves, used to assess 
the growth of children by recording the anthropometric estimations dependent on the age 
and gender of the child. Percentiles and z-scores are portrayed as a numeric summary of each 
child`s placement relative to an appropriate reference population on a growth chart, to give 
the most exact measure of protein-energy malnutrition (Collins et al., 2010; Lee & Nieman, 
2016). 
There are two sets of growth charts in use today, these are: 
2.7.1.3.7.1 The growth charts published by the Centers of Disease Control and 
Prevention (CDC)  
These growth charts depend on pooled information from five National Health and Nutrition 
Examination surveys. CDC growth charts developed for assessing length-for-age and 
weight-for-age in females and males from birth to two years of age. The CDC has created 
growth charts for females and males for two age intervals: birth to two years, and 2 to 20 
years. The charts for the age interval from birth to two years give percentile curves for 
length-for-age, weight-for-age, weight-for length, and head circumference-for-age. For the 
age intervals 2 to 20 years, the charts give percentile curves for stature-for-age, weight-for-
age, and body mass index for- age, and weight-for stature, these charts suggested for use in 
evaluating the growth and development of children from birth till 20 years of age (Lee & 
Nieman, 2016). 
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2.7.1.3.7.2. The World Health Organization growth charts  
Percentiles and z-scores are utilized to assess the anthropometric estimations of infants and 
children in order to assess their growth and nutritional status (World Health Organization., 
2008). Z-scores are said to have a number of advantages compared to percentiles in that they 
are determined dependent on the distribution of the reference population; mirror the 
reference distribution and are compared across ages, sexes and anthropometric estimations 
(World Health Organization., 2008). Z-scores can also be analyzed as a continuous variable 
in studies and can along these lines be utilized to evaluate the extreme growth status at the 
two ends of a distribution (World Health Organization., 2008). 
Weight-for-age and length-for-age when utilized on a proper growth chart are an marker of 
a child`s weight and length compared with other children of a similar age and sex and is the 
most useful tool to track weight gain in children. Anyway, weight-for-age isn't utilized to 
classify a child as underweight or overweight (Bunting et al., 2013). Length-for-age is a 
useful tool to measure the direct growth of a child. Also, it represents the long-term 
nutritional status of a child and is influenced more gradually than weight when a child 
experiences under or over nutrition. Under-nutrition as a rule causes poor linear growth or 
stunting (Bunting et al., 2013). 
Weight-for-length is utilized as an indicator for normal weight or underweight and 
overweight as the body weight is dependent on a child`s stature. A weight-for-length value 
beneath the fifth percentile is demonstrative of under-nutrition and a weight-for-length value 
over the 95th percentile is characteristic of over nutrition. BMI-for-age is the most reliable 
method of predicting a visual assessment of underweight or over-weight in a child. A BMI-
for-age less than the fifth percentile are characteristic of under-weight (Bunting et al., 2013). 
2.7.1.4 Biochemical assessment  
Laboratory tests that are most of the time used to evaluate the nutritional status of children 
include: 
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2.7.1.4.1 Albumin  
The most recognizable and abundant of the serum proteins, similarly as the most readily 
accessible clinically, is albumin. Serum albumin level has been appeared to be a marker of 
depleted protein status and reduced dietary protein intake (Lee & Nieman, 2016).  
In addition, serum albumin utilized as a marker of nutritional status because of its long half-
life of 21 days and its ability to be influenced by specific drugs, for example, corticosteroids, 
insulin and thyroid hormones; dehydration and certain illness states, for example, severe 
liver, renal disease, intravascular volume overload, mal-absorption disorders, chemotherapy 
and zinc deficiency, so its utilization as a marker for malnutrition (Madrono et al., 2011). 
Studies have demonstrated hypo-albuminemia to be a marker for both malnutrition and 
severe inflammation (Nieuwoudt, 2011). Normal range of albumin is between 3.5-5 g/l , 
mild depletion 3.0-3.4 g/l, moderate depletion 2.5-2.9 g/l , severe depletion ≤ 2.4g/l (Lee  & 
Nieman, 2016). 
2.7.1.4.2 Hemoglobin 
Hemoglobin conveys oxygen and the levels of its measure the blood's ability to carry 
oxygen. Low serum hemoglobin and hematocrit levels are common in children receiving 
chemotherapy and can likewise be falsely high in patients who are dehydrated (Madrono et 
al, 2011). Anemia has an essential relation with anthropometric markers that evaluate the 
depletion of lean mass; the BMI has a strong relation with all the anthropometric parameters 
evaluated, as well as the albumin and except with the values of hemoglobin (De Jesus et al., 
2018). 
2.7.1.4.3 Pre-albumin 
Pre-albumin otherwise called transthyretin and thyroxin-binding pre-albumin, is 
incorporated in the liver and as a carrier protein for retinol-binding protein.  Has a shorter 
half-life than albumin (Lee & Nieman, 2016). Serum Pre-albumin and retinol binding protein 
distinguishes as better indicators of current protein intake and nutritional status in children 
(Mosby, et al., 2009).  
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2.7.2 Nutritional intervention in ALL patients 
Any illness that causes physiological stress and expanded catabolism can significantly 
increase a child’s nutritional requirements (Tomlinson & Kline, 2010). The development of 
early and appropriate nutritional interventions holds the guarantee of improving the 
malignancy patient’s ability to experience and tolerate definitive oncological treatments, 
including surgery, radiation, chemotherapy, and the expanding variety of  more up to date 
treatments, including biological response modifiers, angiogenesis inhibitors, monoclonal 
antibodies, and other focused-on therapies. Usage of nutritional management can give a 
constructive and empowering background for the patient and family during malignancy 
therapy (Tomlinson & Kline, 2010). 
2.7.2.1 Oral feeding 
Child oral feeding with family participation is vital to enable families to overcome the side- 
reactions of malignant treatment (a loss of appetite, nausea, vomiting, mucositis and 
stomatitis) which adversely impact a child`s oral intake. The majority of children was found 
to require a balanced age-appropriate diet with food fortification to make foods and snacks 
more energy, dense with or without the expansion of high calorie oral nutritional 
supplements and nutrition education on eating issues identified with the symptoms of 
treatment. In a hospital setting system, treatment timings were found to interfere with eating 
times. Patients were admitted for long periods of time which made meals repetitive and 
boring. One study addressed this issue by providing a cook to arrange administration with 
individualized age- proper portion sizes, child-friendly cutlery and crockery and the 
provision of snacks for the duration for children who can’t tolerate full meals (Bauer et al., 
2011).  
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2.7.2.2 Nutritional support methods  
Studies reported that approximately 46 % of children with malignancy experience 
malnutrition because of the disease and because of complications that may emerge due 
to chemotherapy, for example, mucositis; food aversion coming about because of 
vomiting; and nephrotoxicity which causes increased nutrient losses (Bauer et al, 2011; 
Owen et al, 2013). Steroids initiate hyperglycemia, fluid retention, weight gain, altered 
body composition and electrolyte imbalances (Owens et al., 2013). Children undergoing 
chemotherapy regularly experience taste and smell changes, these chemosensory 
changes can influence the perceived flavor of oral nutritional supplements frequently 
prescribed (Owens et al., 2013).  
Previous research regarding the palatability of oral nutritional supplements in pediatric 
malignancy patients experiencing chemotherapy is deficient. 
 
A study by Ijpma and others (2016) recommended offering a variety of types and flavors 
to malnourished malignant patients throughout the treatment time frame. Enteral and 
parenteral nutrition are two means for conveying nutrition to individuals who can't 
digest food normally. The mechanisms are different, yet the general objective is the 
same: to be specific, to give nutrition and typically medicine directly into patients’ 
bodies (Ijpma et al., 2016). 
 
a- Enteral nutrition  
Enteral tube feeding is the delivery of fluid supplements through a tube directly into the 
gastrointestinal tract. In pediatric cases, it is utilized for children and infants with a 
working gastrointestinal (GI) tract who are not ready to orally ingest sufficient nutrients. 
Multiple studies prescribed improving the nutritional status of children by utilizing 
nasogastric tube feeds during intensive malignant treatments including bone marrow 
transplantation with insignificant complications (Selwood et al., 2010).  
Enteral formulas containing intact protein were observed to be well tolerated during 
chemotherapy cycles, in any case; following chemotherapy, protein hydrolysate and amino 
acid based formulas were observed to be better tolerated as children may show diminished 
gastrointestinal motility with a hazard for mal-absorption (Selwood et al., 2010). 
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b- Parenteral nutrition  
Parenteral nutrition (PN) is suggested for patients whose enteral feeding diets are unable 
to provide adequate nutrients, is utilized fundamentally for nutrition support when 
physician order to keep patient NPO (nil per os) nothing per mouth. Research concludes 
that parenteral nutrition ought to be saved for children who can't tolerate enteral feeding 
because of an abnormal gastrointestinal function either related to the treatment or the 
tumor. In pediatric malignant patients, it is for the most part utilized for those with 
medications that are given intra-thecal, severe mucositis or neutron-peniccolitis 
(Nieuwoudt, 2011). According to Nieuwoudt (2011), parenteral nutrition is more 
effective than enteral nutrition in well-nourished children and young people with 
malignant diseases experiencing chemotherapy. 
2.7.2.3 Use of dietary supplements 
The utilization of multivitamin and mineral supplements is suggested in the case of poor 
oral intake in children with cancer. Vitamins when given in excess cause lethality 
therefore administration of mega doses of a single vitamin are not encouraged. Children 
receiving nutritionally complete sip feeds and those on an enteral feeding regime will 
not require additional vitamins as their requirements will be met by the sip feed / 
formula (Nieuwoudt, 2011). In addition, Glutamine supplementation has been 
prescribed in the relief of extreme mucositis (Nieuwoudt, 2011). The American 
Academy of Pediatrics has suggested that the utilization of pre and probiotics be kept 
away from seriously or chronically sick children until the safety of administration has 
been set up (Nieuwoudt, 2011). According to Rickard and others (1986), dietary 
enhancements are needed to make up for the decrease in antioxidants that happens 
because of malignant medications(Rickard et al., 1982). 
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2.8 Physical activity 
The World Health Organization (WHO) defines health as a state of complete physical, 
mental, and social well-being. So, the illness is not just the medical issues, but also prolonged 
physical inactivity including bed rest is a priority public health problem, and it is related to 
malignancies (Jagoe, Goldberg, 2001).  Physical activity is characterized as any bodily 
movement created by skeletal muscles that requires energy expenditure including exercises 
undertaken while working, playing, doing family tasks, travelling, and engaging in 
recreational activities (World Health organization, 2018). Childhood and adolescence are 
critical periods for developing movement skills, learning healthy habits, and setting up a 
firm establishment for lifelong health and well-being (“Physical Activity Guidelines for 
Americans,” 2008). 
 Regular physical activity in children and adolescents’ advances wellbeing and wellness. 
Contrasted with those who are sedentary, physically active youth have higher levels of 
cardiorespiratory wellness and stronger muscles(“Physical Activity Guidelines for 
Americans,” 2008). 
In addition, child who is normally active additionally get an opportunity of a healthy 
adulthood. And the expression "physical activity" ought not to be mistaken for "exercise", 
which is a subcategory of physical activity that is arranged, structured, repetitive, and 
expects to improve or keep up at least one segments of physical fitness. 
Whatever, other physical activity that is finished during relaxation time, for transport to get 
to and from places, or as a major aspect of an individual’s work, has a health advantage. 
Further, both moderate- and vigorous-intensity physical activity improve wellbeing. 
Globally, 81% of adolescents aged 11-17 years were deficiently physically active in 2010. 
Adolescent girls were less active than adolescent boys, with 84% versus 78% not meeting 
WHO recommendation. Evidence recommends how even moderate levels of physical 
activity or high fitness levels are related to advantages for the wellbeing in children and 
adolescents.  
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Physical inactivity is the main cause of increasing percentage of obesity and overweight, 
which are basic in children with Acute Lymphoblastic Leukemia (ALL) (Ness et al., 2005). 
In addition, physical activity can likewise help controlling BMI and overweight as energy 
balance.  Therefore, it is essential for a nutritional program for malignant patients to likewise 
incorporate an extra physical activity to expand the calories burned and to maintain the loss 
of muscle mass (Huang, 2011).  
Also, physical activity for malignant patients improved quality of life for malignant patients 
and reduced danger of cardiovascular illness in disease survivors. The 2008 physical activity 
guidelines for Americans from the US Department of Health And Human Services 
recommend that children and adolescents should do 60 minutes (1 hour) or more of physical 
activity daily. 
According to world health organization (WHO), 2018 prescribes that the Children and 
adolescents aged between 5-17 years should not to less than an hour of moderate to vigorous-
intensity physical activity every day. In addition, the physical activity of amounts more 
noteworthy than an hour every day will give extra health benefits. So, the activities that 
strengthen muscle and bone, must to do it around 3 times each week. 
Physical activity guidelines for children between 6–17 years according to 2008 physical 
activity guidelines for Americans are: 
1- Aerobic: most of an hour or more a day should be either moderate or vigorous intensity 
aerobic physical activity, and must include vigorous- intensity physical activity at least 
3 times each week. 
2- Muscle –strengthening: as part of their one hour or more of daily physical activity, 
children and adolescents should include muscle-strengthening physical activity at least 
3 times each week. 
3- Bone-strengthening: as part of their one hour or more of daily physical activity, children 
and adolescents should include bone-strengthening physical activity on at least 3 times 
each week(“Physical Activity Guidelines for Americans,” 2008). 
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2.9 Approaches to increase physical activity in children 
Children should be encouraged to move and engage in active play as well as in structured 
activities, such as bicycle or tricycle riding. Young children should do activities that involve 
hopping, skipping, jumping, and tumbling to strengthen bones and muscles. In addition, to 
improve bone health and avoid excess fat in young children they may need 3 hours per day 
of activity of all intensities: light, moderate, or vigorous intensity. This is the average amount 
of activity observed among children and is consistent with guidelines from Canada, the 
United Kingdom, and the Common wealth of Australia (“Physical Activity Guidelines for 
Americans,” 2008). 
2.10 Conceptual framework: 
This study aimed to describe the ALL disease and socio-demographic factors that are related 
to nutritional status and physical activity in children with Acute Lymphatic Leukemia in 
Palestine. The study is intended to put new policies about dietary habits and physical activity 
for children with acute lymphatic leukemia. Also, to implement educational sessions for 
acute lymphatic leukemia patients about dietary habits, problems that affects nutritional 
status and physical activity during treatment. 
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2.11. Study variables and operational definitions 
2.11.1 Dependent variables  
Acute Lymphoblastic Leukemia (ALL): It may be defined as a neoplastic disease that 
affects the blood-forming tissues of the bone marrow, lymph nodes, and spleen (Tmilson & 
Kline, 2010). 
2.10.2 Independent variables 
Gender: Either male or female. 
Age: Age of child in years. 
Occupation: It is a job or profession that the parents doing, that is, the activities that bring 
an income for the families, it is classified as employed and un-employed. 
Parent education level indicates the years of studying that has been finished or the top 
degree that has been achieved, elementary school contemplating (1-10) years, secondary 
(11-12) years, and college or university anything other than 12 years. 
Family income: The average of cash earned by the relatives in the same home. 
Nutritional status: The assessment of the state of nourishment of a patient or subject 
(“Mosby’s Dental Dictionary,” 2008).The nutritional status was assessed and calculated on 
the basis of weight-for-age, height-for-age, BMI-for-age by plotting in Z-score Growth 
Chart, as classified by WHO. 
Z-score: The deviation of an individual’s value from the median value of a reference 
population, divided by the standard deviation of the reference population (World Health 
organization, 1997). 
Arm Muscle Area (AMA)-for-age: Anthropometric measurement of muscle mass 
(“Mosby’s Dental Dictionary,” 2008). It’s calculated using the upper-arm circumference, 
thickness of the triceps skinfold.  
Serum Albumin: The main serum protein of the blood in humans and other vertebrates, 
produced in the liver and active in the maintenance of blood osmotic pressure, and in the 
transport of fatty acids, steroids, and other compounds, including many drugs (“Mosby’s 
Dental Dictionary,” 2008). The albumin level normal range is between 3.5-5 g/l, mild 
depletion 3.0-3.4 g/l, moderate depletion 2.5-2.9 g/l , severe depletion less than 2.4g/l. 
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Serum hemoglobin: a conjugated protein in red blood cells, comprising globin and iron-
containing heme, that transports oxygen from the lungs to the tissues of the body (“Mosby’s 
Dental Dictionary,” 2008). The acceptable hemoglobin level according to age, from 1-6 
years the acceptable level is between 9.5-14g/dl, from 6-18 years the accepted hemoglobin 
is between 10-15.5 g/dl. 
Physical activity level: Physical activity is defined as any bodily movement produced by 
skeletal muscles that requires energy expenditure including activities undertaken while 
working, playing, carrying out household chores, travelling, and engaging in recreational 
pursuits (World Health organization, 2018). It’s classified as recommendation level and 
below recommendation level according to WHO. 
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Chapter Three: Methodology 
 
The reason for this chapter is to determine the study design, study sample, methods used to 
collect and analyze the data to accomplish the aims and objectives of the study. 
3.1 Setting of the study: 
The study was conducted at Beit-Jala governmental hospital in Bethlehem. Beit-Jala 
Hospital is the only general governmental hospital in Bethlehem province. It is composed of 
300 employees, 65 doctors & 165 nurses in different departments with the capacity of 136 
beds. Beit-Jala hospital is one of the largest centers of paediatric haematology and oncology 
in Palestine. In Beit-Jala Hospital, children with ALL are treated with chemotherapy, and 
children who need other types of treatment are transferred to specialized hospitals outside 
the country.  
3.2 Study design: 
This research is a quantitative cross-sectional descriptive study was conducted from January 
2018 to August, 2018 using questionnaires and anthropometry measure. Pediatric ALL cases 
in all stages were recruited from those who were on treatment according to ALL treatment 
protocols at Huda Al Masri paediatric hematologic oncology department at Beit-Jala 
governmental hospital in Bethlehem city. 
 A control group consisted of healthy children who were recruited from the outpatient clinic 
at Beit-Jala hospital. Children in the cases group were matched to those in the control group 
in a ratio of 1:2 based on age and gender. This approach aim to provide data about nutritional 
status and physical activity level for pediatric patients with Acute Lymphatic Leukemia 
(ALL) in comparison to their healthy counterpart. 
3.3 Target population: 
Target population of this study were Palestinian children with ALL age between 2-12 years, 
diagnosed and being treated at Huda Al-Masri paediatric hematologic oncology department 
at Beit-Jala governmental hospital in Bethlehem. 
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A control group consisted of healthy Palestinian children age between 2-12 years who were 
recruited from the outpatient clinic at Beit-Jala hospital. 
3.4 Sampling methodology: 
According to the previously mentioned aims of this cross-sectional study, as a rare disease, 
we have selected control group from healthy children who visited the outpatient clinic at 
Beit-Jala hospital. Matching was done according to age and gender and we have selected all 
pediatric ALL cases diagnosed and being treated at Huda Al Masri pediatric hematology 
oncology department at Beit-Jala hospital in Bethlehem.  ALL patients aged 2- 12 years old 
have been enrolled in the study. 
In addition, a control group of healthy children have been selected to match patients aged ± 
6 months, healthy children were matched to the cases by age and gender, and they were 
selected from healthy children who were visiting outpatient pediatric clinics in Beit-Jala 
hospital. 
The total number of study participants was 63 children, in which 21 were children with Acute 
Lymphoblastic Leukemia (ALL), and 42 were healthy children.  
3.5 Inclusion criteria: 
Palestinian children with ALL 
1. Age between 2-12 years after confirmed diagnosis of ALL. 
2.  All children diagnosed and being treated at Huda Al- Masri paediatric hematologic 
oncology department at Beit-Jala governmental hospital in Bethlehem during data 
collection period. 
3. A control group consisted of healthy Palestinian children age between 2-12 years who 
were recruited from the outpatient clinic at Beit-Jala hospital. 
3.6 Exclusion criteria: 
For both cases and control children who have: 
1. Dawn syndrome 
2. Other chronic illnesses affecting appetite or weight regulation as GI disease. 
3. Those with severe rheumatoid arthritis, or wheel – chair bound. 
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4. Growth abnormalities, failure to thrive. 
5. Were on intravenous fluid were excluded. 
3.7 Study tools 
Multiple sources of data were used during this study to achieve goals: 
1. Electronic medical record:  pediatric ALL patient files in the hospital contain 
information about their social status, medical condition, medications, stage of treatment,  
lab test , follow up and visits details. 
2. Questionnaire that included: 
a. The socio-demographic data 
b. Physical activity data 
c. Dietary assessment, including servings per days of some types of food. 
3. Anthropometry data 
a. Seca portable balance scale and stadio-meter for the measurement of child 
weight and height, respectively. 
b. Triceps Skinfolds thickness measurement caliper. 
c. Measuring tape to measure Mid-Upper-Arm Circumference (MUAC). 
 
3.8. Pilot study, reliability and validity  
The questionnaire was tested for face validity with referral to 5 experts in the field 
(Dieticians, Academics, Statisticians, Leukemia Specialist Doctor).  
A pre-designed questionnaire and 3 days food records were given to ten participants in the 
pilot study who were randomly selected; 5 participants from Huda Al-Masri center and the 
other 5 participants from out-patients pediatric clinic, who were chosen to show the ability 
of participants to fill comfortably. 
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In piloting process, the researcher found some statements that need rephrasing. Some 
questions were completely replaced. Results from the pilot study pointed that the 
questionnaire would provide the needed data to meet the objective of the study. The 
researcher solicited participants` comments and considered them in the questionnaire final 
drafting. In this pilot study, the time of completing the whole questionnaire was 12-15 
minutes. The response rate was 100% and completion rate were 70%.  
Although three days foods record was given to ten participants in the pilot study who were 
randomly selected with a full explanation on how to fill them, the response rate was 50% 
and completion rate was 10 % of the participants, so the researcher cancelled the three days 
record. 
 
3.9 Measures: 
3.9.1. Socio-demographic data:  
Socio-demographic data include date of birth, sex, and age, and social status, residency 
place, family income level, parent’s occupation and parent’s level of education. 
3.9.2 Anthropometric data:  
A. weight (kg) and height (cm) were measured using seca portable balance scale and 
stadiometer, Body Mass Index (BMI)-weight/height², weight-for-height, weight-for-age and 
their Z-scores were determined according to WHO growth charts. The results of weight, 
height and BMI were compared to WHO (world health organization) normative data in 
children. BMI- for-age z-score characterizes overweight as more than 1SD, values more than 
2SD were considered to represent obesity, values less than    -2SD were considered to 
represent thinness. In addition, less than -3SD were considered to represent severe thinness. 
B. Mid upper arm circumference (MUAC) was measured to the closest 1mm using 
measuring tape. the mid-point between the olecranon process of the ulna and the acromial 
process of the scapula with the lower arm held at right angle and a mark was made at this 
point. A plastic estimating tape was passed around the arm at the mark. The measuring was 
repeated three times and the mean of the three measurements was used to calculate Arm 
Muscle Area (AMA).  
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C. Triceps skinfold thickness (TSF) was measured utilizing a GIMA caliper (Gima S.p.A- 
Gessate (MI)- made in Italy) to the closest 0.1 mm at a similar level of the site utilized for 
the MUAC. Lifting the skin and fat away from hidden muscle tissue with one hand and 
applying the caliper jaws to either side of this fold of skin, the reading was determined 2–3 
seconds after the full pressure of the jaws of the caliper had been applied. The estimation 
was repeated three times within 1 mm of the past one and the mean of the three estimations 
was utilized for calculating Arm Muscle Area (AMA).  
D. Arm muscle area AMA (estimated in mm²); was calculated by researcher.  The result of 
AMA percentile was compared using a form that adapted from Frisancho (1990). 
The standard equation for calculating arm muscle area (AMA) is 
AMA= [𝑴𝑨𝑪 − (𝝅 × 𝑻𝑺𝑭)]𝟐 ÷ 4π 
3.9.2 Physical activity (PA) 
PA was assessed using physical activity questionnaire for children that are intended for use 
through personal interview. The questionnaire asks about duration and intensity of physical 
activity then the comparison has been done by using the recommended level for age 
according to WHO. 
3.9.3 Dietary habits  
Were assessed using a questionnaire, intended for use through personal interview. The 
questionnaire asks about the average intake from food groups (vegetables, fruits, milk ) then 
the comparison have been done  using the recommended level for age and gender according 
to the American academy of pediatrics which is valid for children between 2-18 years old 
(klienman,2009). 
3.10 Data analysis: 
 Data analysis was carried out using the SPSS software, version 22. Values of all studied 
variables were displayed as counts and percentages. Mean, standard deviations, T-test, Chi-
square, one-way ANOVA (analysis of variance) were also performed. The difference was 
considered significant when the p-value was ≤0.05. 
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3.11 Ethical considerations 
1. The research was evaluated and agreed by the research committee in the School of Public 
Health at Al Quds University. 
2. Ministry of Health approval to perform the study and collect data in Beit-Jala pediatric 
clinic and Huda-AL Masri ward was also taken. 
3. The consent form of the family on the participation in this study, after explanting the aim, 
objective and the confidentiality of the collected data, was signed. 
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Chapter Four: Data Analysis and Results 
 
In this chapter we will present the analysis methods that were used and the results which 
embrace the distribution of participants by frequencies and percentages with mean and 
standard deviations. Also, the results of comparing means by using dependent t-test and 
ANOVA, chi square test will be presented to indicate the associations between dependent 
and independent variables. 
 
4.1 Descriptive statistics 
A total of 63 children participated in this study, of which 21 were children with acute 
lymphoblastic leukemia (ALL), and 42 were healthy children. With respect to the children 
with ALL and healthy children 38% of them were males and 62% were female children. 
Their average age was 7.2 years. As for the place of residence, 43% of the children with 
acute lymphoblastic leukemia (ALL) were from Hebron Governorate, 24% were from Gaza 
strip, and 19% were from Bethlehem Governorate. However, the majority of healthy 
children were from Bethlehem governorate (93%).  The table 4.1 presents the main 
characteristics of the children under study. 
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Table 4.2: Distribution of study participants according to age, sex, place of residence and 
district. 
  
Children 
With 
ALL 
Healthy 
Children  
Number of children under study  21 42 
Age  Average Age  7.24 7.23 
Sex 
Male 38% 38% 
Female 62% 62% 
Place of residence 
Village 48% 52% 
City 43% 40% 
Camp 10% 7% 
District 
Hebron 43% 2% 
Bethlehem 19% 93% 
Ramallah 5% 2% 
Gaza 24% 0% 
Other districts 10% 3% 
 
 
With regard to the anthropometric of the participated children, the study showed that the 
average z-score for Body Mass Index BMI-for-age for the children with ALL was 0.75 SD, 
while the average z-score BMI-for-age for the healthy children was 2.2 SD. Also, the average 
z-score weight-for-age for the children with ALL was 0.34SD, while the average z-score 
weight-for-age for the healthy children was 0.73SD.  In addition, the average z-score for 
length-for-weight for age for the children with ALL was -0.73 SD, while the average z-score 
for length-for-weight for the healthy children was 0.02 SD. 
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As for Serum Albumin, the data indicates that the average Serum Albumin for Acute 
lymphoblastic leukemia children is 4.45 g/dl, while the average is 4.61 g/dl for healthy 
children. 4% of children with ALL in the present study have mild depletion in Albumin 
level; while no one of the healthy children have depletion in Albumin level, this can be 
attributed to the continuous follow-up of albumin level in children with leukemia at Beit-
Jala hospital, and the hospital protocols to give albumin if the patient has low level. 
 As for children with ALL, 33% of them are in the third stage of treatment, and 19% of them 
are in the first and the second stage. Only 14% of the children are in the fourth and the fifth 
stages. The protocols of treatment at Beit-Jala hospital divided to five  stages (Induction A, 
Induction B, Consolidation , Re-induction , Maintenance ).The figure 4.1 presents these data.  
 
 
 
     Figure 4.1: Distribution of study participants with ALL by treatment stage 
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With regard to the family status, the data revealed that 43% of the fathers of the children 
with ALL are employed, whereas 51% of the fathers of the healthy children are employed. 
In contrast, 81% of the mothers of the children with ALL are unemployed, and 73% of the 
mothers of the healthy children are unemployed. The main difference between the two 
groups may refer to the economic status, as 35% of the families with ALL children have 
income less than 1500 NIS (New Israeli Shekel) per month, and only 5% of the families with 
ALL child have income that exceeds 5000 NIS per month. On the contrary, 22% of the 
families with no ALL children have income more than 5000 NIS per month. Moreover, only 
17% of the families with no ALL children have an income that is less than 1500 NIS per 
month. Additionally, 83% of the families with no ALL children are living in their own 
property, but only 67% of the families with ALL children are living in their own property. 
Also, it was noted that 24% of the families with ALL child are living in the family house. 
The table (4.2) and the figure (4.2) exemplify these finding 
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           Table 4.3: Main characteristics of the families of the children under study. 
Variable  Category  ALL 
Child 
(N=21) 
Healthy 
children 
(N=42)  
The family lives in 
owned property 67% 83% 
Rented house 10% 8% 
Family house 24% 10% 
Father's occupation 
Employed 86% 95% 
Unemployed 14% 5% 
Mother's occupation 
Employed  19% 27% 
Unemployed  81% 73% 
Average number of education years 
(Father) 
11.3 11.1 
Average number of education years 
(Mother) 
12.6 12.9 
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Figure 4. 2: Distribution of study participant’s families by family income (NIS month)  
 
Regarding the source of information about nutrition, 52% of the parents of the children with 
ALL reported that they get nutrition information from health specialists (doctors and nurses), 
while only 37% of the parents of the healthy children reported the same. It was noted that 
the majority of the parents of the healthy children are receiving their information regarding 
the nutrition of their children from friends and surrounding people (63%). Additionally, 24% 
of the parents who have children with ALL reported that they receive nutrition information 
for their children from a nutrition specialist. Only 12% of the parents with healthy children 
reported the same. Finally, it was noted that both groups don’t consider newspapers or the 
internet as a source of information for their children nutrition. The figure (4.3) shows the 
source of nutrition information for both groups.in addition the total number of children who 
seen a nutritionist in the last six months are 5 children and its only 7%, this number is not 
enough to extract or generalize results. 
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  Figure 4.3: The source of nutrition information for the participant’s families 
 
With regard to the gastrointestinal complications, the data revealed that 43% of children with 
ALL have nausea, 50% of children with ALL have vomiting, 5% of children with ALL have 
diarrhea, 23% of children with ALL have general weakness, 28% of children with ALL have 
mouth ulcer and 50% of children with ALL have anorexia . In contrast, none of the healthy 
children have any gastrointestinal complications  
 
4.2 Research questions  
Study Question Number 1: Is there a difference between healthy children and ALL patients 
in the nutritional status, dietary habits and physical activity? 
Study Question Number 2: What are the factors that may affect the nutritional status and 
physical activity during treatment of children with ALL? 
Study Question Number 3: Are there any differences between healthy children and children 
with ALL in growth? 
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4.3 Dietary habits 
The research didn’t neglect the dietary habits for children with ALL and their relationship 
to differences in nutritional status. In addition, the researcher tried to use the three days 
record, and after the researcher didn’t get cooperation from participants of the pilot study, 
the researcher decided to use a questionnaire about the dietary habits, but these questions are 
not sufficient to determine the nutritional causes contributing to the nutritional status. But 
before getting into the results, it’s important to note that 90% of the children with ALL and 
83% of the healthy children do not take dietary supplements such as vitamins. More 
importantly, none of the children under study is suffering food allergy. Nonetheless, the data 
showed that the majority of healthy children (83%) tend to eat any kind of food (solid, liquid 
or soft), while only 52% of patient children eat any kind of food (solid, liquid or soft). 
  
The results of the analysis revealed that 71% of the children with ALL take a normal 
breakfast every day. As well, 83% of the healthy children are doing the same. Also, the data 
revealed that 62% of the children with ALL take a morning snack daily compared to 66% of 
healthy children. With regard to lunch, both groups reported almost the same, where all 
children with ALL and 95% of healthy children take lunch every day. In the afternoon it 
seems that healthy children tend to eat more as 66% of them take afternoon snack compared 
to 43% of children with ALL.  Moreover, 93% of healthy children tend to eat a dinner daily 
compared to 76% of children with ALL.  
 
In addition, it has been found that patient children prefer to eat meat, pastries and yogurts 
more than healthy children. On the other hand, healthy children prefer to eat vegetables more 
than children with ALL.  But in general, the results found that both groups do eat fruits, 
sweets, eggs, and Carbohydrates at the same level.  
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The same goes with drinks. The only exception case is water. The data showed that 71% of 
patient children are likely to drink water daily, but this percentage decreased to 34% at 
healthy children. In addition, the data revealed that carbonated soft drinks like Cola are 
widely used among healthy and patient children. For example, 32% of patient children and 
39% of healthy children consume cola daily. Additionally, 11% of patient children and the 
healthy children consume these drinks 3 times (180 ml) per day. In addition, sweets and 
candies are consumed extensively among the 2 groups where the results found that 55% of 
the children with ALL and 68% of the healthy children do consume sweets and candies more 
than 3 times per day.  
Regarding fast foods, the data revealed that this kind of food is not widely consumed among 
children with ALL as 74% of them did not take fast food in the last 7 days. It was also noted 
that 91% of the ALL children eat at home and only 9% of them eat at restaurants. Regarding 
healthy children, the results showed that 40% of them had eaten less than one fast food in 
the last 7 days and 20% of them ate one fast food in the last 7 days. Moreover, 2.5% of them 
took 2 fast meals in the last 7 days. 
However, the data revealed that children with ALL don’t have healthy dietary habits. But 
there was no significant differences between children with ALL and healthy children. This 
emphasizes the important of nutrition counseling for patient & healthy children. The data 
analysis found that only 14% of patient children had visited a nutritionist in the last six 
months.   
 4.4 Research hypothesis 
      To answer the first and the third questions of the study the researcher set 8 hypotheses.  
1- There are no statistically significant differences at α= 0.05 between children with Acute 
lymphoblastic leukemia (ALL) and healthy children in their z-score of weight-for-age. 
 
2- There are no statistically significant differences at α= 0.05 between children with Acute 
lymphoblastic leukemia (ALL) and healthy children in their z-score of Body Mass 
Index-for-Age. 
 
3- There is no statistically significant association between children with Acute 
lymphoblastic leukemia (ALL) and healthy children in their AMA (Arm Muscle Area). 
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4- There are no statistically significant differences at α= 0.05 between children with Acute 
lymphoblastic leukemia (ALL) and healthy children in their z-score weight-for-height. 
 
5- There are no statistically significant differences at α= 0.05 between children with Acute 
lymphoblastic leukemia (ALL) and healthy children in their physical activity level. 
 
6- There are no statistically significant differences at α= 0.05 between children with Acute 
lymphoblastic leukemia (ALL) and healthy children in their fruits servings for child per 
day according to age.  
 
7- There are no statistically significant differences at α= 0.05 between children with Acute 
Lymphoblastic Leukemia (ALL) and healthy children in their milk servings for child 
per day according to age. 
 
8- There are no statistically significant differences at α= 0.05 between children with Acute 
lymphoblastic leukemia (ALL) and healthy children in their vegetable’s servings for 
child per day according to age. 
 
4.5 hypothesis tests 
1- To test the first hypothesis “There are no statistically significant differences between 
children with Acute Lymphoblastic Leukemia (ALL) and healthy children in their z-score 
weight-for age’’, the researcher used descriptive statistics, the independent-samples t-test 
and a Chi square test . The result of the test revealed that p-value is 0.307 which is greater 
than the value of α (0.05). Thus, we accept the first hypothesis, and we conclude that there 
are no statistically significant differences in the z-score weight-for-age between children 
with Acute Lymphoblastic Leukemia (ALL) and healthy children. This means that the 
weight-for-age of children with ALL is not different than the weight-for-age of healthy 
children under the z-score standards. The tables (4.3) show the results of the t-test.  
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Table 4.4: Independent samples T-test for the first hypothesis “There are no statistically 
significant differences between children with Acute Lymphoblastic Leukemia (ALL) and 
healthy children in their z-score of weight-for age’’ 
  t-test for Equality of Means 
T P-value 
Mean 
Difference 
Std. Error 
Difference 
Z-score 
for 
Weight-
for-age z-
score 
Equal variances 
assumed 
-
1.031 
0.307 -
0.38874 
0.37695 
Equal variances not 
assumed 
-
0.938 
0.356 -
0.38874 
0.41437 
 
 
In addition, the researcher used a Chi square test for the categories of weight-for-age. The 
result showed that the significance of the test was 0.001, which was less than 0.05. Thus, the 
researcher concluded that there are a statistically significant differences in the weight-for-
age between children with ALL and healthy children.  
To see the source of difference the researcher did additional analysis to study the weight-
for-age categories for the 2 groups under the study. For example, 81% of the healthy children 
have good nutritional status compared to only 38% of the children with ALL. Most notably, 
43% of the children with ALL suffer moderate malnutrition, while only 5% of the healthy 
children are suffering the same. Also, 14% of the children with ALL are overweight, whereas 
12% of the healthy children are the same. The full results can be seen in Figure (4.4). 
According to the WHO, it is important to note that the cut-off point of the weight-for-age 
below -2 SD is classified as moderate malnutrition. In addition, those below -3 SD are 
classified as severe malnutrition, while those with z-score more than +2 SD are classified as 
overweight. Z-score between +2 SD and -2 SD are classified as good nutrition (World Health 
organization, 1997). 
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Figure 4.4:classification of study participants according to their weight-for-age categories 
 
2- To test the second hypothesis “There are no statistically significant differences at α ≥ 0.05 
between children with Acute Lymphoblastic Leukemia (ALL) and healthy children in their 
z-score of Body Mass Index-for-Age” the researcher used descriptive statistics and the 
independent-samples t-test. The outcomes of the test disclosed that the p-value of the test is 
0.45 which is greater than the value of α (0.05). Accordingly, we accept the hypothesis, and 
we assume that there are no statistically significant differences in z-score of Body Mass 
Index-for-Age between children with Acute lymphoblastic leukemia (ALL) and healthy 
children. This implies that the z-score of BMI-for-age of children with ALL is not different 
than the z-score of BMI-for-age of healthy children. The tables (4.4, 4.5) present the results 
of the t-test. 
 
Table 4.5: Independent samples T-test for the second hypothesis “There are no statistically 
significant differences at α ≤ 0.05 between children with Acute lymphoblastic leukemia 
(ALL) and healthy children in their z-score of Body Mass Index-for-Age” 
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  t-test for Equality of Means 
T P value 
Mean 
Difference 
Std. Error 
Difference 
Body 
Mass 
Index 
for 
Age 
Status 
Equal variances 
assumed 
-.755 0.453 -
2.45476 
3.24939 
Equal variances 
not assumed 
-1.052 0.298 -
2.45476 
2.33337 
 
 
 
 
Table 4.6: Descriptive statistics of Z-scores for BMI-for-age for both groups of participants 
under study 
  N Mean St. 
Error 
St. Dev Min Max 
ALL Children 21 0.603 0.467 2.138 2.56 3.99 
Healthy Children 42 0.938 0.215 1.393 2.24 3.88 
 
 
However, BMI (Body Mass Index) was created as a risk indicator of disease. This means 
that the increase of BMI will increase the risk of some diseases such cardiovascular diseases, 
high blood pressure, osteoarthritis, some cancers and diabetes. 
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Additionally, the researcher used a Chi square test for the categories.  The result showed that 
the p-value of the test was 0.124, which was greater than 0.05. Thus, the researchers 
concluded that there wasn’t an association in the BMI-for-age between children with ALL 
and healthy children.  
Therefore, the researcher did additional analysis to study the BMI-for-age categories for the 
2 groups under the study. The aim of the additional analysis was to examine if the high 
average of BMI-for-age for the children with ALL or for the healthy children. According to 
WHO, it is important to note that the cut-off points of the BMI-for-age reference for children 
overweight is defined as a BMI-for-age value over +1 standard deviation (SD), obesity as a 
BMI-for-age value over +2( SD), thinness as a BMI- for-age value below -2(SD) and severe 
thinness as a BMI-for-age value below -3(SD) .  
The results found that 55% of the healthy children are in good nutrition while only 38% of 
the children with ALL are in good nutritional status. Furthermore, 24% of the children with 
ALL do have obesity. On the other hand, only 19% of the healthy children do have obesity. 
Most notably, the data revealed that 14% of the children with ALL are suffering severe 
thinness, while none of the healthy children are suffering such condition. In addition, 10% 
of the children with ALL are suffering thinness, whereas only 7% of the healthy children are 
classified thin according to the BMI-for-age. 
Generally, these results indicate that the BMI-for-age according to categories in healthy 
children is better than the BMI-for-age status for the children with ALL. This also implies 
that the nutritional status of healthy children is significantly better than the nutritional status 
of the children with ALL. The figure (4.5) illustrates these findings in a more comprehensive 
way.  
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Figure 4.5: Classification of study participants according to their BMI- for- age category 
 
3- To test the third hypothesis “there are no statistically significant association between 
children with Acute Lymphoblastic Leukemia (ALL) and healthy children in their Arm 
Muscle Area (AMA) categories; first of all, it is important to note that the cut-off points 
and guidelines for interpreting the AMA -for-age/sex percentile reference for children 
according to Frisancho (1990) classifies the Values for Arm Muscle Area as shown in 
table (4.6). 
 
Table 4.7: Guidelines for Interpreting the Age/Sex Percentile Values for Arm Muscle Area 
Percentile Category 
≤ 5𝑡ℎ Wasted 
> 5 𝑡ℎ 𝑏𝑢𝑡 ≤ 15𝑡ℎ Below average 
> 15 𝑡ℎ 𝑏𝑢𝑡 ≤ 85𝑡ℎ Average 
> 85𝑡ℎ 𝑏𝑢𝑡 ≤ 95𝑡ℎ Above average 
> 95𝑡ℎ High muscle 
    Adapted from Frisancho AR. 1990.Anthropometric standards for the assessment 
severe thinness thinness obesity overweight
good nutritional
status
Children with ALL 14% 10% 24% 14% 38%
Healthy children 0% 7% 19% 19% 55%
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        of growth and nutritional status. Ann Arbor: University of Michigan Press. 
 
The researcher used descriptive statistics and the "Pearson Chi-Square" test. The result of 
the test revealed that (Chi-Square = 13.036, DF = 4, Sig. = 0.011) which is less than the 
value of α (0.05). Thus, the researcher rejects the third hypothesis, and the researcher 
concludes that there is statistically significant association between AMA categories and 
children disease status. This means that the disease status of the children is a key factor that 
determines the child Arm muscle area (AMA).  
Nevertheless, the Chi-Square Tests cannot detect which group has the highest AMA. 
Therefore, the researcher used descriptive statistics for this purpose. The descriptive 
statistics disclosed that 45% of healthy children have Arm muscle area (AMA) within the 
recommended average, while only 24% of the children with ALL have AMA within the 
recommended average.  
Also, 26% of the healthy children have high muscles, whereas only 10% of the children with 
ALL have high muscles. Most notably, 62% of the children with ALL are classified with 
wasted muscles. On the other hand, only 19% of the healthy children are classified the same. 
The data also revealed that the AMA of 7% of the healthy children and 0% of the children 
with ALL are classified below average. What is more, the AMA of 5% of the ALL children 
and 2% of the healthy children is classified above average. 
 As mentioned previously, Arm muscle area is utilized as an index of lean tissue or muscle 
in the body and represents muscle protein reserves .Thus, the researcher concludes that the 
muscle protein reserves in healthy children is significantly higher than the muscle protein 
reserves in children with ALL. The figure (4.6) represents these findings in a more 
comprehensive manner.   
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Figure 4.6: AMA categories classifies according to percentile of study participants 
 
4- To test the forth hypothesis “There are no statistically significant differences at α ≥ 0.05 
between children with Acute Lymphoblastic Leukemia (ALL) and healthy children in 
their z-score of weight-for-length”. The researcher used descriptive statistics and the 
independent-samples t-test. The outcomes of the test disclosed that the p-value of the 
test is 0.045 which is less than the value of α (0.05). Therefore, the researcher rejects 
the hypothesis, and the researcher accepts that there are statistically significant 
differences in z-score of weight-for-height between children with Acute Lymphoblastic 
Leukemia (ALL) and healthy children. The table (4.7) presents the results of the t-test. 
 
 
 
 
Table 4.8:Independent Samples T- Test to testing the relation between children disease 
status and weight-for-height 
above average average below average high muscle wasted
Children With ALL 5% 24% 0% 10% 62%
Healthy children 2% 45% 7% 26% 19%
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  t-test for Equality of Means 
t P-value 
Mean 
Difference 
Std. Error 
Difference 
Height-
for- age 
nutritional 
z-score 
Equal 
variances 
assumed 
-2.043 .045 -.75595 .36999 
Equal 
variances 
not assumed 
-1.956 .058 -.75595 .38649 
 
But the t-test cannot detect which group has the highest or the lowest “weight-for-height 
categories”. The researcher used a Chi square test.  The result showed that the p-value of the 
test was 0.011, which was less than 0.05. Thus, the researcher concluded that there is a 
statistically significant differences in the weight-for-height between children with ALL and 
healthy children.  
 Thus, the researcher used descriptive statistics for this reason. The descriptive statistics 
showed that 88% of the healthy children are in good nutritional status, while only 48% of 
the children with ALL are in good nutritional status. Also, 34% of the children with ALL 
are in malnutrition, while only 5% of healthy children are in malnutrition. The figure (4.7) 
shows all the results.   
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Figure 4.7: Distribution of study participant according to their weight-for-height 
classification (z-score) 
 
In addition, it is important to note that the cut-off points of the weight-for-height when z-
score below -2 (SD) are classified as stunting. In addition, those below -3 (SD) are classified 
as severe malnutrition, between +2(SD) z-score and -2(SD) z-score are classified as good 
nutritional status (World Health organization, 1997).  
 
5- To test the fifth hypothesis “There are no statistically significant differences between 
children with Acute Lymphoblastic Leukemia (ALL) and healthy children in their physical 
activity level”. First of all, It is important to note that the cut-off points for physical activity 
levels was done according to WHO recommendation level for children, which should 
indicate that children do physical activity at least 60 minutes (1 hour) 3 times each week. 
The researcher used descriptive statistics and the Pearson Chi-Square" test. The result of the 
test revealed that significance is 0.000 which is less than the value of α (0.05). Thus, the 
researcher rejected the fifth hypothesis, and the researcher concluded that there are 
statistically significant differences in physical activity level between children with Acute 
Lymphoblastic Leukemia (ALL) and healthy children. This means that physical activity 
between the 2 groups is significantly different.  
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Though, the Pearson Chi-Square test cannot detect which group has the highest or the lowest 
level of physical activity. Therefore, the researcher used descriptive statistics for this 
purpose. The descriptive statistics disclosed that the 86% of the healthy children are on the 
recommended level of physical activity, while only 24% of the ALL children are on the 
recommended level. On the other hand, 76% of the children with ALL are below the 
recommended level of the physical activity, and only 14% of the healthy children are on that 
level of physical activity. The figure (4.8) shows details of these findings.  
 
 
Figure 4.8: Description of the study participants according to their physical activity level 
 
6- To test the 6th hypothesis “There are no statistically significant association between 
children with Acute Lymphoblastic Leukemia (ALL) and healthy children in their 
intake of  fruits servings per day” First of all, It is important to note that the cut-off 
points of the fruits-for-age servings are used according to the Recommendations of the 
American Academy of Pediatrics table (4.8) details these findings (Kleinman, 2009).  
 
Table 4.9:Recommendations for fruit intake, milk & dairy products & vegetables 
(servings/day) for children according to age (Kleinman, 2009). 
below level recommandation level
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Healthy children 14% 86%
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Age  2-3years 4-8 years 9-12years 
Daily amounts of fruits 
recommended by 
American Academy of 
Pediatric 
1 cup 1 cup 1 1/2cup 
Daily amounts of milk 
recommended by 
American Academy of 
Pediatric 
2 cups 2 cups 3cups 
Daily amounts of 
vegetables 
recommended by 
American Academy of 
Pediatric 
1 cup 1 1/2 cup 2cups 
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The researcher applied descriptive statistics and the Pearson Chi-Square test. The result of 
the test revealed that significance = 0.009 which is less than the value of α (0.05). Thus, the 
researcher rejected the 6th hypothesis, and the researcher concluded that there are statistically 
significant differences in fruits intake (servings per day) between children with Acute 
Lymphoblastic Leukemia (ALL) and healthy children. This means that daily consumption 
of fruits of the 2 groups is significantly different.  
Again, the p-value of the Chi-Square test cannot detect which group has the highest fruit 
consumption. Therefore, the researcher utilized descriptive statistics for this reason. The 
descriptive statistics showed that 83% of the healthy children are on the recommended level 
of fruits consumption, while only 52% of the ALL children are on the recommended level. 
On the other hand, 48% of the children with ALL are below the recommended level of fruits 
consumption, and only 17% of the healthy children are on that level of fruits consumption. 
This mean that fruits intake of healthy children is better than those children with ALL. The 
figure (4.9) details these findings.   
 
Figure 4.9: Distribution of the study participants according to their fruits intake level based 
on American Academy Of Pediatric recommendation 
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7- To test the 7th hypothesis “There are no statistically significant association between 
children with Acute Lymphoblastic Leukemia (ALL) and healthy children in their intake of  
milk servings per day” It is important to note that the cut-off points of the milk-for-age 
servings are used according to the Recommendations of the American Academy of 
Pediatrics. Table  (4.8) details these recommendations (Kleinman, 2009). 
The researcher applied descriptive statistics and the Pearson Chi-Square test. The result of 
the test found that the significance= 0.028 which is less than the value of α (0.05). 
Consequently, the researcher rejected the 7th hypothesis, and the researcher decided that 
there are statistically significant differences in milk intake (Servings per day) between 
children with Acute Lymphoblastic Leukemia (ALL) and healthy children. This implies that 
the daily consumption of milk within the 2 groups is significantly different.  
Nonetheless, the t-test cannot uncover which group has the highest or the lowest level of 
milk consumption. For this purpose, the researcher used descriptive statistics. The 
descriptive statistics showed that 29% of the healthy children are on the recommended level 
of milk intake, while only 5% of the ALL children are on the recommended level. On the 
other hand, 95% of the children with ALL are below the recommended level of the milk 
consumption, and 71% of the healthy children are on that level of milk intake (serving per 
day). This means that healthy children have significantly higher level of milk consumption. 
However, these results are worrying since both groups do consume milk below the 
recommended level.  The figure (4.10) details these findings.  
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Figure 4.10: Distribution of the study participants based on their milk consumption level 
according to the American Academy of Pediatrics recommendation 
 
8- To test the 8th hypothesis “There are no statistically significant association between 
children with Acute Lymphoblastic Leukemia (ALL) and healthy children in their 
intake of vegetables servings per day”. It is important to note that the cut-off points of 
the vegetables intake  are used according to the recommendations of the American 
Academy of Pediatrics table (4.8) details these findings (Kleinman, 2009). 
The researcher applied descriptive statistics and the Pearson Chi-Square test. The result   
of the test revealed that significance at 0.047 which is less than the value of α (0.05). 
Accordingly, the researcher rejected the 8th hypothesis, and the researcher concluded 
that there are statistically significant differences in vegetables intake serving per day, 
between children with Acute lymphoblastic leukemia (ALL) and healthy children. This 
means that the consumption of vegetables of the 2 groups is significantly different.  
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As the signicancy at 2 sided is unable to detect which group has the highest or the lowest 
vegetable consumption, the researcher employed descriptive statistics. The descriptive 
statistics revealed that 50% of the healthy children are on the recommended level of 
vegetable consumption, while only 24% of the ALL children are on the recommended 
level. On the other hand, 76% of the children with ALL are below the recommended 
level of vegetable consumption, and 50% of the healthy children are on that level of 
consumption. This mean that vegetable intake of healthy children is better than those 
children with ALL. The figure (4.11) details these findings.   
 
 
Figure 4.11: Distribution of the study participants based on their vegetables intake level 
according to AAP recommendation. 
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4.6 Study Question Number 2 
 What are the factors that may affect the nutritional status and physical activity level during 
treatment of children with ALL? 
To answer this question the researcher used descriptive statistics; t-test; One-way ANOVA; 
and Pearson Chi-Square test for the suggested factors with nutritional status and physical 
activity. The factors are: Children’s gender; Place of residence; Family income; and stage of 
treatment. 
First of all the researcher found that the total number of children who took cortisone is 5 
children with ALL. This number is not enough to extract or generalize results. Thus, the 
researchers drop this option. 
1- Child gender: 
The descriptive statistics with the t-test and the Pearson Chi-Square test revealed that child 
gender does not affect the nutritional status and physical activity level during treatment of 
children with ALL. The results of the t-test showed that the p-value for the z-score of weight-
for-age is 0.211 and the p-value for the z-scores of BMI-for-age nutritional status was 0.487. 
The P-value for AMA categories was 0.159. Additionally, the P-value for the association 
between child gender and the physical activity level is 0.920. All these values are greater 
than 0.05. Therefore, the researcher concluded that there are no significant differences in 
nutritional status and physical activity level during treatment of children with ALL that can 
be attributed to the child gender. Table (4.9) shows these results. 
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Table 4.10: Results of t-test and Chi-square test to show the relation between gender of the 
ALL children group and their nutritional status, physical activity and daily intake of different 
food groups. 
ALL children by gender  N 
Statistical 
test 
P-
vale  
Result  
Weight-for-
age  
Male 8 
t-test 0.211 
No 
difference Female 13 
BMI-for-
age  
Male 8 
t-test 0.487 
No 
difference Female 13 
AMA  
Male 8 Chi-
Square 
0.159 
No 
difference Female 13 
Weight-for-
height 
Male 8 
t-test 0.940 
No 
difference Female 13 
Physical 
activity 
level 
Male 8 
Chi-
Square 
0.920 
No 
difference Female 13 
Fruits 
Servings 
Per Day 
Male 8 
Chi-
Square 
0.284 
No 
difference Female 13 
Milk 
Servings 
Per Day 
Male 8 
Chi-
Square 
0.191 
No 
difference Female 13 
Vegetables 
Servings 
Per Day 
Male 8 
Chi-
Square 
0.920 
No 
difference Female 13 
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2. Place of residence 
To study the effect of the place of residence on child with ALL, the researcher used the 
descriptive statistics, the One-Way ANOVA, and Chi-Square test. The results of the 
ANOVA test revealed that the place of residence has no effects on weight-for-age (P-Value 
0.280) and weight-for-height (P-value = 0.90), and on BMI-for-age nutritional status (P-
value 0.482). Also, the Chi-Square test revealed that there is no association between place 
of residence and AMA (P-value = 0.777). Likewise, there is no association between the place 
of residence and Physical activity level (P-value = 0.654), and there is no association 
between the place of residence of children with ALL and their daily consumption of fruits, 
milk, and vegetables (P-values = 0.793; 0.561; and 0.238 respectively). Tables (4.10a ,b) 
illustrate these results. 
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Table 4.11 a.: Results of one-way ANOVA and Chi-square tests to show the relation between 
place of residence of the ALL children group and their nutritional status, physical activity and 
intake of different food groups 
Variables Place of 
residence 
N Statistical 
test 
P vale 
Weight-
for-age  
City 9 
One Way 
ANOVA 
0.280 Village 10 
Camp 2 
BMI-for-
age  
City 9 
One Way 
ANOVA 
0.482 Village 10 
Camp 2 
AMA  
City 9 
Chi-
Square 
0.777 Village 10 
Camp 2 
Weight-
for-height 
City 9 
One Way 
ANOVA 
0.90 Village 10 
Camp 2 
Physical 
activity 
level 
City 9 
Chi-
Square 
0.654 Village 10 
Camp 2 
Fruits 
Servings 
Per Day 
City 9 
Chi-
Square 
0.793 
 
Village 10 
Camp 2 
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Table 4.10 b.: Results of one-way ANOVA and Chi-square tests to show the relation between 
place of residence of the ALL children group and their nutritional status, physical activity and 
intake of different food groups 
Variables Place of 
residence 
N Statistical 
test 
P vale 
Milk 
Servings 
Per Day 
City 9 
Chi-
Square 
0.561 Village 10 
Camp 2 
Vegetables 
Servings 
Per Day 
City 9 
Chi-
Square 
0.238 Village 10 
Camp 2 
 
3-Family income:  
To study the effect of family income on the nutritional status and physical activity during 
the treatment, the researcher used the descriptive statistics, the One-Way ANOVA, and Chi-
Square test. The results revealed that family income has no effect on any of the factors under 
study. For example: The results of the ANOVA test revealed that family income has no 
effects on weight-for-age (P-Value = 0.926) and weight-for-height (P-value = 0.528), and 
on BMI-for-age (P-value 0.570). Also, the Chi-Square test revealed that there is no 
association between family income and AMA (P-value = 0.7457). Likewise, there is no 
association between family income and Physical activity level (P-value = 0.269), and there 
is no association between family income of children with ALL and their daily consumption 
of fruits, milk, and vegetables (P values = 0.254; 0.582; and 0.2086 respectively. Tables 
(4.11a ,b) illustrates these results. 
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Table 4.11 a.: Results of one way ANOVA and Chi-square tests to show the relation between family 
income of the ALL children group and their nutritional status, physical activity and intake of different 
food groups. 
 
 Variables 
Monthly Income  N 
Statistical 
test 
P value  
Weight for 
age status 
Less than 1500 NIS 7 
One Way 
ANOVA 
0.926 
1500 – 3000 7 
3000 – 5000 5 
More than 5000 2 
BMI for age 
nutrition 
status 
Less than 1500 NIS 7 
One Way 
ANOVA 
0.570 
1500 – 3000 7 
3000 – 5000 5 
More than 5000 2 
AMA for age 
status 
Less than 1500 NIS 7 
Chi-Square 0.457 
1500 – 3000 7 
3000 – 5000 5 
More than 5000 2 
Height for 
age status 
Less than 1500 NIS 7 
One Way 
ANOVA 
0.528 
1500 – 3000 7 
3000 – 5000 5 
More than 5000 2 
Physical 
activity level 
Less than 1500 NIS 7 
Chi-Square 0.269 
1500 – 3000 7 
3000 – 5000 5 
More than 5000 2 
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Table 4.11 b.: Results of one way ANOVA and Chi-square tests to show the relation between 
family income of the ALL children group and their nutritional status, physical activity and 
intake of different food groups. 
 
 Variables 
Monthly Income  N Statistical 
test 
P value  
Fruits for 
Age 
Servings 
Per Day 
 
Less than 1500 NIS 7 
Chi-
Square 
0.254 
1500 – 3000 7 
3000 – 5000 5 
More than 5000 2 
Milk for 
Age 
Servings 
Per Day 
 
Less than 1500 NIS 7 
Chi-
Square 
0.582 
1500 – 3000 7 
3000 – 5000 5 
More than 5000 2 
Vegetables 
for Age 
Servings 
Per Day 
 
Less than 1500 NIS 7 
Chi-
Square 
0.086 
1500 – 3000 7 
3000 – 5000 5 
More than 5000 2 
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4- Stage of treatment 
To study the effect of stage of treatment on the nutritional status and physical activity during 
treatment of children with ALL, the researcher used the descriptive statistics supported with 
One-Way ANOVA test and Chi-Square test. The results revealed that stage of treatment has 
no significant effect on the nutritional status and physical activity during treatment of 
children with ALL. Tables (4.12 a., 4.12 b.) show the results. 
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Table 4.12 a .: Results of one way ANOVA and Chi-square tests to show the relation 
between stage of treatment for the ALL children group and their nutritional status, physical 
activity and daily intake of different food groups. 
Variables Treatment stages N Statistical 
test 
significance 
Weight-for-age  
First Stage 4 
One Way 
ANOVA 
0.415 
Second Stage 4 
Third Stage 7 
Forth Stage 3 
Fifth Stage 3 
BMI-for-age  
First Stage 4 
One Way 
ANOVA 
0.572 
Second Stage 4 
Third Stage 7 
Forth Stage 3 
Fifth Stage 3 
AMA  
First Stage 4 
Chi-Square 0.619 
Second Stage 4 
Third Stage 7 
Forth Stage 3 
Fifth Stage 3 
Weight-for-
height 
First Stage 4 
One Way 
ANOVA 
0.404 
Second Stage 4 
Third Stage 7 
Forth Stage 3 
Fifth Stage 3 
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Table 4.12 b.: Results of one-way ANOVA and Chi-square tests to show the relation between stage of treatment 
for the ALL children group and their nutritional status, physical activity and daily intake of different food groups 
Variables  Treatment stages N Statistical test significance 
Physical 
activity level 
First Stage 4 
Chi-Square 0.350 
Second Stage 4 
Third Stage 7 
Forth Stage 3 
Fifth Stage 3 
BMI-for-age  
First Stage 4 
Chi-Square 0.178 
Second Stage 4 
Third Stage 7 
Forth Stage 3 
Fifth Stage 3 
AMA  
First Stage 4 
Chi-Square 0.363 
Second Stage 4 
Third Stage 7 
Forth Stage 3 
Fifth Stage 3 
Weight-for-age 
First Stage 4 
Chi-Square 0.566 
Second Stage 4 
Third Stage 7 
Forth Stage 3 
Fifth Stage 3 
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    Chapter Five: Discussion  
 
5.1 Introduction  
All methods for clinical appraisal of nutritional status have limitations , particularly in 
children with malignancies (Sala et al, 2005). 
There are no studies on the nutritional status of children with cancer that have been 
performed in Palestine. A national survey was completed in 2010 by Palestinian Central 
Bureau of Statistics (PCBS) included children below 5years old in the Gaza Strip, West Bank 
and Palestinian territory, and used anthropometric parameters recommended by the WHO. 
Prevalence of underweight in normal children was 3.8% in west bank, 3.5% of children were 
considered underweight in Gaza Strip (PCBS, 2012). 
Leukemia was the most common malignancy among Palestinian children in the West Bank 
in 2015 (Palestinian MOH, 2016). Malnutrition as evaluated using anthropometric measure 
can influence clinical results in pediatrics with Acute Lymphoblastic Leukemia (ALL). 
Malnutrition has long been recognized as an important component of adverse outcomes 
among patients with malignancies, including expanded mortality and morbidity and 
diminished quality of life. The incidence of malnutrition in this study was high similar to the 
findings of  Viana and others (Viana et al., 1994). 
In addition, nutritional status can be evaluated by several approaches that are 
anthropometric, biochemical, dietary and clinical. Weight, height and body mass index are 
used for most clinical indicators in nutritional status (Wright et al, 1994).  
In this study, ALL patients were chosen to have a similar type of malignant disease (Acute 
Lymphoblastic Leukemia) and got similar kind of malignancy treatment (chemotherapy) 
under similar treatment protocols and policies. In addition, patients and healthy controls 
were similar based on their age and gender. This study aims to access the nutritional status 
and physical activity level of pediatric patients with ALL during treatment in Beit-Jala 
hospital and compare them to healthy children. 
 
 
  
70 
 
5.2 ALL Sample and characteristics 
The multiple protocols of chemotherapy for ALL generally include the following phases: 
Induction, consolidation, Re-induction, CNS-directed therapy, Maintenance/continuing 
treatment (Tmilson & Kline, 2010).  
In the present study, patients were recruited mostly during the consolidation stage, which is 
the third period of treatment.  On the other hand, a study done by Tan and others (2010) 
found that childhood obesity has been detected during the latter part of ALL treatment 
especially during the maintenance phase, which is the fifth period of treatment. 
The peak age for children with ALL in this study was between 6-9 years old. While there is 
lack of published studies in Palestine on the incidence of children with ALL. The  result of 
this study is similar to a study done by Sala & others (2011) in a total of 2954, aged 1–18 
years, that found the peak age 6.9 years old.  
Another study conducted by Pillay & colleagues (2017) in Abu Dhabi on twenty pediatric 
patients with ALL found the peak age range of children to be between 1 to 2 years old (Pillay 
etal., 2017). The Middle Eastern study directed by Al-Mulla & others (2014) on 1150 
pediatric patients with ALL found that the peak age range of children with ALL was between 
3-6 years old which was similar to the age range reported in western nations (Al-Mulla et 
al., 2014). Another study conducted by Lughetti & others (2012) found the peak age of ALL 
occurrences in children to be between 2- 6 years old (Lughetti et al., 2012). 
The ratio of males to females in this study was determined to be 1:1.5(males: females) which 
wasn’t the same as from the sex-based incidence ratio of 1.4: 1 (males: females) conducted 
by Al-Mulla & colleagues (2014). Different studies published by The Cancer Oncology 
Group (2015) and a study by Gholami & colleagues (2013) revealed that the prevalence of 
ALL to be marginally more common in males than in females, however, the reason of this 
differences between males to females ratio because this study didn’t aim at finding the 
prevalence, this study is just taking the available cases in this hospital which isn’t necessarily 
representative (Al-Mulla et al., 2014; Gholami et al., 2013). 
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5.3 Anthropometric measures 
In this study anthropometric measurements for all subjects were recorded as z-scores for 
weight-for-age, height-for-age and BMI-for-age on the World Health Organization (WHO) 
growth charts. Several factors may influence weight, including medications, diet, and lack 
of physical exercise. 
Weight-for-age, height-for-age and BMI-for-age are considered as the most sensitive indices 
for growth in children (Selwood et al., 2010). The incidence of malnutrition in children with 
ALL was high in the present study, ranged from 24-62 %, depending on the measurement 
used, which is similar to Tazi & colleagues (2008), and in contrast to other studies (Danaher 
et al., 2006; Donaldson, 1982; Oquaz et al., 1999). Other research published by Maldonado-
Alcazar & his colleagues (2013) found that the prevalence of malnutrition in children with 
ALL  in 76 studies to be 7% for children living in developed countries and 21-23% for 
children living in developing countries (Maldonado-Alcázar et al., 2013). 
a. BMI-for-age 
In this study, 24% of children with ALL were found to have under-nutrition when BMI-for-
age z-score was utilized. In addition; the results indicate that there was no significant relation 
between the stage of treatment and nutritional status. As Tan & others (2013) in their cross-
sectional research, who investigated the prevalence  of malnutrition utilizing a BMI-for-age 
Z-score, classified 15.1% of patients as undernourished, though different studies (Syahrul 
et, 2011; Zalina et al., 2009). Which is similar to a study done by Sala and others (2011) in 
a total of 2954 children with cancer, aged between 1–18 years, found that 28% of children 
with cancer were underweight based on BMI-for-age categories and 20% were severely 
malnourished. 
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Another prospective cross-sectional study done by Murphy and others (2015) when BMI-
for-age was used to define underweight, 8% of the on-treatment group was considered 
underweight. In contrast to study done by Collins and colleagues (2010), that included more 
than 1000 ALL children in Australia and found that the BMI-for-age z-score gave a good 
estimation of protein- energy malnutrition. These investigators detailed that around 48% of 
children with cancer in their study as being undernourished (Collin et al., 2010). Another 
study done by Tazi & colleagues (2008) includes one hundred pediatric patients with cancer 
with the mean age was 7 years (range 1 to 18 years) found that 38% of children with cancer 
had Malnutrition using BMI-for-age. However, the reason of these differences in 
percentages between studies results might be attributed to the sample size and the country 
where the study was done (developed or developing country). 
On the other hand, obesity is also a current worry among leukemic children. The present 
study demonstrated that 24% of children with ALL were overweight, as revealed by the Z-
score distribution of BMI-for-age. In addition, it was exhibited that children with leukemia 
were generally experiencing a higher prevalence of under-nutrition, instead of over-
nutrition, according to various nutritional indices. On the other hands, the study done by Tan 
and others (2013) on 53 pediatric patients diagnosed with ALL and undergoing 
chemotherapy treatment found a large number of patients in his study to be overweight as 
opposed to underweight, as appeared by the percentile distribution of different 
anthropometric indices. 
In addition, the previous studies revealed obesity in pediatrics with leukemia noticeably 
during the third part of their therapy (Reilly et al., 1999; Tan et al., 2013). In contrast to the 
present study results revealed that stage of treatment has no significant effect on the 
nutritional status and physical activity during treatment of children with ALL. However, the 
reason of these differences between studies results might be attributed to the sample size. 
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b. Weight-for-age 
In this study, the incidence of under-nutrition  was 48% when weight-for-age was chosen as 
the nutritional indicator, which is higher the results that found by Tazi & others (2008) in a 
cross-sectional study indicating that  37% of children had under-nutrition based on weight-
for-age (Tazi et al., 2008). In addition, this results higher than that found by Viana & 
colleagues, indicating that 21.2% of children with ALL had a weight-for-age Z-score of less 
than –2 SD (Viana et al., 1994). 
In this study, subjects on treatment for ALL experienced changes in nutritional status as 
shown by a decrease in growth, weight gain and weight loss. Several factors such as diet, 
treatment-related side-effects of chemotherapy, high doses of steroids received during every 
treatment stage and a lack of physical activity were possible reasons for the observed 
changes in weight. 
 
c. Weight-for-height 
In this study, the incidence of under-nutrition was 34% of children with ALL when weight-
for-height was chosen as the nutritional indicator, which is higher than the results found by 
Tazi & others (2008) in a cross-sectional study indicating that 20% of children had under-
nutrition by weight-for-height. A study done by Oquaz & colleagues revealed that weight-
for-height was unaffected nutritional indicator with disease and treatments.  
Similar to the previous studies, the results of the present study revealed that there were no 
significant statistical differences in weight-for-age, weight-for-height, BMI-for-age z-scores 
between children with ALL and healthy children (Murphy et al., 2006; Murphy ,White& 
Davies, 2010; Murphy et al., 2015). In contrast to other study done by Fuemmeler & others 
(2013) that revealed there was a significant difference between cases and controls with 
respect to the change in BMI-for-age z-score from baseline to 12 months (Fuemmeler et al., 
2013). 
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d. Arm anthropometry 
Subsequently, arm anthropometry is also suggested as a tool for nutritional status assessment 
since it is more sensitive and less confounded (Antillon et al., 2013). Particularly in cases 
whereby the weight of a child may be influenced by edema (Reilly et al., 1999).  
In previous studies, arm anthropometry recognized a higher prevalence of malnutrition in all 
kind of malignancies than the conventional weight and height based parameters (Oquaz et 
al., 1999; Tazi et al., 2008; Viana et al.,1994). This can be clarified by the fact that the 
presence of ascites or edema can mask the effect of nutritional depletion on body weight, 
and secondly; when faced with nutritional restrictions, the body initially uses its nourishing 
stores in the form of skeletal muscle protein and fat (Lee & Nieman, 2016). 
In this way, catabolism of lean body mass is a common impact of the disease, making the 
assessment of body composition a basic part of the evaluation of such patients. The result 
found that the large number of malnourished children in this study is related to chemotherapy 
and medications, children and adolescents with cancer present issues with their weight 
measurements due to malignancy effects such as edema. Along these lines, measurement of 
body composition is an essential procedure in assessing patients in several situations, 
especially with regard to catabolic diseases (Garofolo& Sarni, 2002). 
The present study revealed that arm anthropometry detected a higher prevalence of 
malnutrition in children with ALL than the conventional weight and height based 
parameters, comparable findings have been reported in other studies (Kumar et al., 2000; 
Tan et al., 2013). In another study weight-for-height was unaffected but 27% of patients 
were malnourished based on MUAC (med upper arm circumference) and TSFT (triceps 
skinfold thickness) (Oquaz etal., 1999), but 20% of patients were malnourished based on 
MUAC  and 23% based on TSFT.  
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In this study, the result found that there is statistically significant association between AMA 
categories and children disease status. This means that the disease status of the children is a 
key factor that determines the child Arm muscle area (AMA). In addition, the incidence of 
wasted muscles in the present study was 62% when AMA was chosen as the nutritional 
indicator. It ought to be emphasized  that the findings reported by all of the above studies 
did exclude an evaluation of pediatric patients receiving nutritional support (Noor Aini et al, 
2007; Syahrul Bariah et al., 2011; Zalina et al.2009). On the other hand, results reported by 
Tan & colleagues (2013) indicated that only 1.6% of children with cancer have malnutrition 
based on MUAC, it ought to be emphasized that the findings announced by Tan and 
colleagues (2013) study include an assessment of pediatric patients receiving nutritional 
support. 
5.4 Biochemical blood parameters during treatment  
A chemotherapy includes giving high doses of medications to children with ALL in order to 
kill the malignant growth that exists within the bone marrow and also the central nervous 
system in order to avoid relapse (Withycombe et al., 2015). In the present study 28% of 
children with ALL were getting corticosteroids. In addition, only 4% of children with ALL 
in the present study have mild depletion in Albumin level ; while no one of the healthy 
children have depletion in Albumin level,  this can be attributed to the continuous follow-up 
of albumin level in children with leukemia at Beit-Jala hospital, and the hospital protocols 
to give albumin if the patient has low. This is similar to Tazi & others who found that 
biochemical parameters detected a much lower prevalence of malnutrition as compared to 
anthropometric parameters. 
In contrast, Pillay & colleagues (2017) found that 50% of children had hypoalbuminemia at 
the end of consolidation treatment; however, the reason for that difference between studies 
results might be attributed to the characteristics of sample age. In Pillay & colleagues (2017), 
which are sample, age was between 3-4 years old. 
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In contrast, chemotherapy and steroid treatment are likewise known to influence serum 
albumin levels, it must be indicated that an indirect relationship exists between inflammation 
and hypoalbuminemia. Inflammation is known to add to net protein loss in individuals 
because of catabolism; albumin levels need to hence be analyzed in relation to CRP (c-
reactive protein) levels in order to ascertain whether the low albumin levels are because of 
a poor nutritional status or because of inflammation (Selwood et al., 2010). 
Despite the fact that the albumin level was utilized as an indicator of poor nourishing status 
in this study, its utilization to recognize a poor nutritional status in subjects was believed to 
be less important than serum prealbumin. Serum prealbumin which is a progressively 
sensitive marker of nutritional status in children getting chemotherapy was not tested during 
the entire course of chemotherapy. In addition, the hospital protocol is to use serum albumin 
level and isn’t to use prealbumin and C-reactive protein, and thus could be acknowledged as 
a limitation of this study. 
5.5 Dietary habits  
The acceptance of foods is influenced by emotional and psychological factors associated 
with the treatment and the disease itself (Garofolo, 2002). The lower dietary intake among 
children with ALL, related to the side effects of other multi-agent anti-cancer drugs such as 
methotrexate, azacitidine, cytarabine, thioguanine and daunorubicin, which are known to 
cause stomatitis, nausea or vomiting, may have overwritten the effects of corticosteroids, 
subsequently reducing appetite, leading to a reduction in food intake and absorption of 
nutrients (Lai et al., 2005). 
The present study revealed that a high percentage of children with ALL were eating their 
servings of fruits, vegetables and milk below the recommended level by American Academy 
of pediatrics. The data collection in this study was based on time intervals corresponding to 
chemotherapy phases and many patients were assessed during the on and off steroid phase. 
Therefore, patients experienced phases of excessive intake when on steroids followed by 
reduced intake for the rest of the treatment. In addition, the present study revealed that there 
are statistically significant differences in vegetables, fruits and milk intakes (as serving per 
day) between children with Acute lymphoblastic leukemia (ALL) and healthy children. 
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In contrast, another study done by Fuemmeler & others found that there were few differences 
observed between children with leukemia/lymphoma and healthy controls in terms of diet. 
While cases and controls reported consuming, on average, 0 to 2 servings of fruits and 
vegetables per day, which is well below the United States Dietary Association 
recommendation of 5 servings per day. At 12 months of treatment, there were no significant 
differences observed in consumption of dairy products, which was measured discretely in 
servings of milk (Fuemmeler et al., 2013). Another study done by Tan & colleagues found 
that dietary intakes of children with ALL were significantly lower than healthy control 
children. 
However, the reason for this was related to differences in the cut-off- points, where in our 
study we have followed recommendations of the American Academy of Pediatrics (AAP). 
5.6 Physical activity 
In this study, 86% of the healthy children are on the recommended level of physical activity, 
while only 24% of the ALL children are on the recommended level, and the result found that 
there are significant differences in physical activity level between children with Acute 
Lymphoblastic Leukemia (ALL) and healthy children. Several studies examined physical 
activity in children with ALL. However, most studies used accelerometers; a tool which 
measures movement directly is capable of measuring the pattern and intensity of activity. 
Three studies on ALL patients during maintenance therapy used accelerometers to assess the 
Physical activity level (Aznar et al., 2006; Jansen et al., 2009), and found that children with 
ALL were less active than controls, for at least 25% of the  children with cancer were less 
active than controls (Aznar et al., 2006; Jacob et al ., 2007; Winter et al., 2009).  
Although five different studies demonstrated decreased Physical Activity (PA) levels, only 
one study mentioned a possible relationship with nutritional status. This particular study 
showed that both lower levels of PA and increase in BMI were demonstrated in children 
with ALL (Jansen et al., 2009). Unfortunately, this relationship was not tested. Another 
study done by Fuemmeler & colleagues revealed that children with cancer performed 
significantly less moderate/vigorous physical activity than the controls (Pietsch & Ford, 
2000).  
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Physical activity can also play a role in controlling Body Mass Index and obesity as energy 
balance. Therefore, it is important for a nutritional program for cancer patients to also 
include a Physical Activity component to increase the number of calories burned and prevent 
loss of muscle mass (Huang, 2011). 
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Chapter six: Conclusion and Recommendations  
6.1 Conclusion 
The aim of the study is to assess the nutritional status and physical activity level of pediatric 
patients with ALL during treatment at Huda Al -Masri pediatric cancer department at Beit-
Jala hospital and to compare them to healthy children. Although the sample of subjects in this 
study was small it showed that malnutrition is common in children with ALL in Palestine. 
Aggregate findings of this study generally support the previous literature about nutritional 
status and physical activity for children with ALL. 
Based on finding on this study, The prevalence of malnutrition when it is judged based on 
weight-for-age, weight-for-height is less accurate than AMA-for-age. In addition, the 
prevalence of malnutrition in children with ALL is higher than that in healthy children when 
it is judged based on weight-for-age, weight-for-height, BMI-for-age, and AMA-for-age. 
Children who are being treated for ALL present changes in nutritional status, as manifested 
by ALL patients usually develop gastrointestinal complications which results from side 
effects of drugs & disease. In addition, children with ALL don’t have healthy dietary habits. 
However, more educational efforts for parents are needed to promote awareness of engaging 
in healthy eating habits. 
In addition, Children who are being treated for ALL present changes in nutritional status, as 
manifested by malnutrition, which had been identified based on weight-for-age, BMI-for-
age, weight-for-height, AMA-for-age.  
In addition, a few numbers of the children with ALL take dietary supplement. However, only 
a few numbers of children with ALL have visited a nutritionist. So, it’s important to develop 
clear policies; the presence of written policy about nutrition for children with ALL can 
regulate and facilitate the nutritionist rule to reduce the prevalence of malnutrition and to 
improve patient’s lifestyle. In addition, the awareness of the proper nutrition is important to 
improve patient care, and to decrease the prevalence of malnutrition. Early nutrition 
intervention should be considered to prevent weight loss or excessive weight gain as a result 
of treatment-related complications. 
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The prevalence of malnutrition when it based on weight-for-age, weight-for-height is less 
accurate from AMA-for-age and BMI-for-age, as evidence. However, only a few numbers 
of children with ALL have visited a nutritionist. 
The researcher found that children who are being treated for ALL present low level of PA 
compared to WHO recommendation. In addition, Children who are being treated for ALL 
don’t have healthy dietary habits, manifested by low percentage of them taking the 
recommended servings per day fruits, vegetables & milk according to AAP. 
In other hand, oncology department does not assess the children with ALL for nutritional 
problems and if they do, they only use basic weight and height assessments tools methods. 
This may mean that children with ALL who are malnourished may go unrecognized and 
untreated if only their height and weight are considered; thus, their prognosis will be affected 
by their poor nutritional status. Pediatric hematology oncology department need to use more 
accurate methods of accessing nutrition status in children with ALL. In addition, nutritionist 
will monitor the nutritional status and physical activity level for children with ALL. 
6.2 Recommendations  
a. Recommendations for policy makers and hospital administrations 
1. For policy makers and hospital administrations 
2. To develop clear policies on national level about the measurement of nutritional status 
for children with ALL. 
3. Greater awareness raising programs for children with ALL about the health benefits 
derived from physical activity are necessary. 
4. Create a space for physical activity for children with ALL. 
5. To conduct periodical educational workshops about eating habits of ALL children to 
the medical team and the parents. 
6. To improve food services in the hospital. 
 
b. Recommendations for researchers 
1. To do further studies using other methods for measuring physical activity such as 
accelerometer, or measuring energy expenditure of activities for longer time like 7 
days to be more representative of the PA level of children with ALL life style. 
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2. To do more studies using another method of measuring dietary habits such as 3 days 
record to be able to estimate nutrients intake.  
3. To do more methods of measuring nutritional status like using body composition 
machine. 
 
6.3 Limitations: 
1- Not all parts of Palestine were included due to restricted access (Jerusalem & Gaza strip).  
2- Financial: there isn’t a financial support for this project; this project requires financial 
support to expand the scope of the study and to purchase specialized equipment for 
children to accurately measure physical activity and body composition. 
3- The hospital protocol is to use serum albumin level and isn’t to use prealbumin and C-
reactive protein. 
4- Commitment difficulties: most parents weren’t cooperative to fill the 3 days record. 
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 جامعة القدس
 كلية الصحة العامة
 صحية وسياسات ادارة ماجستير
 8102 ستبيانا
 :الاعزاء الاهل
 هذه في المشاركة الى ابوديس، أدعوكم القدس  جامعة في الصحية  والسياسات الادارة ماجستير رولا البندك طالبة انا
للاطفال المصابين بمرض اللوكيميا ومقارنتهم التي تهدف الى تقييم  الوضع التغذوي والنشاط البدني  البحثية الدراسة
القياسات اللازمة (الطول ،الوزن ومحيط  بإجراء لنا والسماح المرفق الاستبيان تعبئة خلال بالاطفال الغير مصابين من
 حةصحي اجابة يوجد لا انه تتذكروا ان حضرتكم من نرجو. طفلكم ملف في الموجودة المعلومات الطبية استعمال و الذراع)
 تامة، المشاركة بسرية طفل لكل المعلومات مع التعامل يتم وسوف اختبار وليست علمية دراسة هذه وان خاطئة، او
 البحث، هذا في المشاركة اخترتم والانسحاب باي وقت تشاؤون ،وإذا الدراسة في المشاركة رفض وبإمكانكم تماما طوعية
 .للطفل القياسات بأخذ والسماح بمصداقية الاسئلة جميع على الاجابة يرجى
 الدراسة: عنوان
 etuca htiw stneitap cirtaidep ni level ytivitca lacisyhp dna sutats lanoitirtun fo tnemssessA"
 ."aimekuel citsalbohpmyl
 على مع رولا البندك التواصل يرجى اسئلة لديكم او اضافية معلومات الى بحاجة كنتم إذاو نشكركم على حسن تعاونكم ،
 7336009650 رقم هاتف
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 اولا : بيانات شخصية:
 الاسم : 1A
 العمر: 2A
 رقم الهاتف الشخصي: 3A
 
 سيتم قياس وتعبئة هذا الجزء من قبل الباحث:
 gK الوزن: 4A 
 mC الطول: 5A 
 2m/gK IMB 6A
 mC :)ecnerefmucric mra reppu dim( CAUM  7A
 mM ssenkciht dlofniks specirT  8A
 
 هذا الجزء سيتم تعبئته من الملف:
 ------------- ld/g :NIMUBLA .S. 9A
 ثانيا : بيانات أساسية:
 . أنثى   2 ذكر.1 الجنس   1B
  2B
مكان اقامة 
 العائلة الحالي
 . مخيم3 . مدينة2 قرية .1
  اسم المحافظة  3B
 . سكن عائلي3 . ايجار2 ملك .1 نوع السكن  4B
  5B
دخل الاسرة 
 شيكل
 0051اقل من  .1
-1051. 2
 0003
 -1003. 3
 0005
. اكثر من 4
 0005
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  6B
عدد سنوات 
تعليم الاب بما 
في ذلك 
 المدرسة
 
  7B
 وظيفة الأب
 الحالية ان وجد
 
  8B
عدد سنوات 
تعليم الام بما 
في ذلك 
 المدرسة
 
  9B
 وظيفة الام
الحالية ان 
 وجدت
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 المصابين باللوكيما:للاطفال 01B-31B الاسئلة من  
 --------------------المرض: . تاريخ اكتشاف B 01
 --------------. عمر الطفل عند اكتشاف المرض:11B
 تاريخ البدء بالعلاج: ـــــــــــــــــــــــــــــــــــــ21B. 
 المرحلة العلاجية:31B.
 الاولى  o
 الثانية  o
 الثالثة o
 الرابعة  o
 الخامسة o
 لجميع الاطفال المشاركين مشتركة الاسئلة
 هل يستعمل طفلك دواء الكورتيزون:41B.
 نعم o
 لا o
 . هل يعاني طفلك من مرض مزمن ؟51B
 نعم  o
 لا o
 
 هل يعاني طفلك من اعاقة حركية؟61B.
 نعم  o
 لا o
 )بامكانك اختيار اكثر من خيارطفلك من اي من الاعراض الاتية ( يعاني. هل 71B
 غثيان o
 تقيء o
 اسهال o
 ضعف عام o
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 تقرحات في الفم  o
 حرقة في المعدة o
 تغير في الشهية o
 ــــــــــــــــــــــــــــــــــــــــــ اخرى ، حدد o
 ؟ ، بامكانكم اختيار اكثر من اجابةالمثلى لطفلكم .من أين تحصلون على المعلومات العامة أو المشورة حول التغذية81B
 ----------------------، حددالعاملين الصحيين o
 ائي التغذيةاخص o
 التلفاز o
 والمجلاتالصحف  o
 الانترنت o
 الراديو o
 المحيطين الاشخاص o
 ـــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ اخرى، حدد o
 . خلال الستة شهور الماضية هل عاين طفلك اخصائي تغذية   :91B
 لم يعاينه ابدا o
 عاينه مرة واحدة o
 عاينه مرتين  o
 ه ثلاثة مراتعاين o
 مرات  4عاينه  o
 مرات وأكثر 5 o
 العادات الغذائية لطفلكثالثا : الاسئلة الاتية لمعرفة 
 يتناول طفلك المكملات الغذائية مثل الفيتامينات؟  له .1C
 لا.2نعم                                                                     .1
 . هل يعاني طفلك من حساسية لنوع ما من الاغذية؟2C
 لا.2                                       --------------، ما هي الاغذية نعم .1
 . ماذا يفضل طفلك ان ياكل عادة ؟3C
 . العصائر او السوائل2                                        اكل طري او مهروس  .1
 . لا يمانع تناول اي نوع من الاغذية4.شوربات                                                             3
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 . اي نوع من الاغذية يفضل طفلك تناولها؟ بامكانك اختيار اكثر من نوع4C
 . عصائر3. فواكه                             2         خضراوات               .1
 . اسماك6. لحوم                              5. سكاكر وحلويات                  4
 .لبن 9. بيض                             8. دواجن                               7
 . معجنات11 . نشويات ( معكرونة ، خبز، ارز )       01
 ماذا يشرب طفلك عادة بشكل يومي؟ بإمكانك اختيار اكثر من خيار5C. 
 . ماء3   . عصير2   . حليب1
                                                  )----(كولا،   غازية مشروبات. 6   . شاي اعشاب5    . شاي4
 ،حدد ـــــــــــــــــــــــــــــــــــغيره. 7
 طفلك في اليوم العادي؟ هل يتناول. 6C
 ــــــــــــــــ . وجبة خفيفة صباحا2   . وجبة الافطار ــــــــــــــــ1
 وجبة خفيفة بعد الظهر_____ .4                            _________.وجبة غذاء3
. وجبة خفيفة قبل النوم______6. وجبة عشاء________                             5
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 رابعا:الاسئلة الاتية لمعرفة الغذاء المتناول لطفلك:
 خلال السبعة ايام الماضية كم مرة في اليوم اكل أو شرب طفلك الاغذية التالية: 
 لم يأكل ابدا نوع الغداء
مرة واحدة في 
 اليوم
 مرتين في اليوم
ثلاث مرات 
 باليوم
مرات في  4
 اليوم
 مرات باليوم 5
 5اكثر من 
 مرات
 (حبة            فواكه 1D
 متوسطة)
       
       عصير الفواكه  2D
 ( كوب)
       
 الحليب او اللبن 3D
 (كوب) 4D
       
        خضراوات  5D
مشروبات غازية  6D
 081(  مثل الكولا
 مل)
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سريعة من  وجبة 7D
 المطاعم
       
        وحلويات  سكاكر 8D
  
 09
 
 
 الماضيةخلال السبع ايام  خامسا :الجزء الاتي من الاسئلة يقيس كمية  النشاط البدني
 
 ايام 7 ايام 6 ايام 5 ايام 4 ثلاثة ايام يومين يوم واحد ولا مرة 
كم يوم قام الطفل  1E
بنشاط بدني حوالي 
 دقيقة على الاقل 06
        
كم يوم قام الطفل  2E
بقيادة الدراجة او 
 المشي
        
 
 :يوميا مجموع الساعات التي يقضيها طفلك في ممارسة النشاط البدني ا. م3E
  .أكثر من ساعة يوم4                                    يوميا  ساعة.             3نصف ساعة. 2  اقل من نصف ساعة. 1
 
 mrof tnesnoC :owt xidneppA
  النشاط البدني للاطفال المصابين بسرطان الدم الليمفاويتقييم الوضع التغذوي و مستوى عنوان الدراسة: 
  
 19
 
 
 الباحثة: رولا بشارة البندك
 جامعة القدس
 
لدراسة وأنه يحق لي الامتناع أو الانسحاب من اأفيد بأنني قد تعرفت على أغراض الدراسة العامة، أساليبها ، متطلباتها، وأعلم أن مشاركت أبني/ أبنتي في هذه الدراسة هي طوعية بحتة 
 في أي وقت . وأعلم بأن هذا البحث سوف يقدم الى لجنة البحوث في جامعة القدس.
 
 
 اسم وتوقيع ولي أمر الطفل/ة:                                 
 
                                    التاريخ:   
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